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ABSTRACT
IN SITU ANALYSIS OF LINE-1 PROMOTER ACTIVITY USING LACZ
TRANSGENIC MICE

PARTHA SARATHI SAHA
2020
Apart from an evolutionary role, transposable elements have been implicated in animal
development and also in pathophysiology. Non-LTR retrotransposons– LINE-1, Alu and
SVA - are responsible for over 120 cases of human genetic diseases as heritable insertions,
and are emerging as an important etiological factor for cancer and neurological disorders
as somatic mutations. It is estimated that among the total number of 500,000 LINE-1s
presents in the human genome, 80-100 LINE-1s remain competent for retrotransposition.
Retrotransposition is only possible when LINE-1 is expressed. Because LINE-1
transcription is regulated by its 5’UTR promoter, it is essential to understand the
spatiotemporal control of LINE-1 promoter activity. The huge abundance, repetitive nature
and complex expression patterns of LINE-1s in the human and mouse genomes necessitate
the development of innovative approaches and the careful design of experimental
procedures used to study these elements. The primary objective of this dissertation was to
develop and validate a mouse model, which can be utilized for studying LINE-1 promoter
activity in vivo. Here, we utilized an in situ staining technique to quantify the endogenous
LINE-1 promoter activity in different organs of the mouse model - to understand any
organ-specific regulation of the mouse endogenous LINE-1 promoter activity. Moreover,
by integrating the transgene into random or specific genomic loci in different orientations,
we characterized the locus-dependent as well as the orientation-dependent expression
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patterns. In all these aspects, we attempted to understand LINE-1 promoter regulation
during different periods of mouse development. Lastly, we also attempted to understand
the cell-specific regulation, especially in the brain. We reported here organ-specific, agelinked, locus-associated, and orientation-dependent LINE-1 promoter activities in the
mouse genome. Out study provides novel insights into LINE-1 biology and the new mouse
model will serve as an invaluable tool to the LINE-1 field.
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Chapter 1
General Introduction

1.1 Transposable elements
Transposable elements describe a unique form of DNA that is mobile in the genome. That
is, transposable elements are sequences that are capable of “jumping” and inserting
themselves into new genomic contexts. The movement of sequences within the genome
can generate a genetic variation by creating new sequences, but transposable elements can
also be disruptive to normal gene function by interrupting gene sequences and producing
mutations.
In humans, the majority of transposable elements have lost their ability to jump around the
genome over evolutionary time, but a few have retained the ability to do so. These
transposable elements that can still insert themselves elsewhere are often referred to as
“transposition competent” (Faulkner and Billon, 2018). Transposable elements those have
lost their ability to jump around the genome have usually done so through acquiring
mutations that disrupt their activity (Bodak et al., 2014).
The functions of these transposable elements are sometimes unclear, they were initially
assumed to be evolutionary remnants of parasitic infection. But more recent evidence
implicates them in a wide variety of processes, including regulating gene expression
(Elbarbary et al., 2016), cell identity (Percharde et al., 2018), and promoting genome
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variation (Richardson et al., 2015). Transposable elements represent almost half of
mammalian genomes (Belancio et al., 2008).
Transposable elements move to new locations in the genome by either by transposition (in
the case of DNA transposons) or retrotransposition (in the case of retrotransposons).
Transposition is a “cut and paste” mechanism, where the element moves from one region
to another, and retrotransposition is a “copy and paste” mechanism, where the element first
makes a copy of itself by reverse transcription and then integrates elsewhere in the genome
(Faulkner and Billon, 2018). This introductory chapter will discuss recent advances in our
understanding of the expression and control of LINE-1 elements, an important class of
retrotransposons and only actively mobile elements in the human genome.
1.2 LINE-1 elements
LINE-1 elements are a member of the family of Long INterspersed Elements (LINEs or
L1s), a family of retrotransposons that are widespread in the mammalian genome, and
present in the genome of other eukaryotes. Retrotransposons require an RNA intermediate
to function as transposable elements, and first make a copy of themselves before jumping
elsewhere in the genome (Boeke et al., 1985). LINE-1 retrotransposons represent a group
of retrotransposons termed non-long terminal repeat (LTR) retrotransposons, reflecting the
genetic structure of the elements (Xiong and Eickbush, 1990).
LINE elements are abundant in eukaryotes and makeup approximately 17.5% and 19.9%
in the human and mouse genomes, respectively (Lander et al., 2001; Waterston et al.,
2002). While most transposable elements in the mammalian genome are inactive, a small
percentage (less than 1%) of LINE-1 elements remain capable of mobilization and
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generating variation in human and mouse genomes (Beck et al., 2011; Faulkner and GarciaPerez, 2017; Goodier et al., 2001). This makes LINE-1 elements a unique and important
class of transposable elements.
The movement and integration of LINE-1 elements in the genome continue to drive
evolution (Ostertag and Kazazian, 2001), but to prevent inappropriate LINE-1 expression
from driving mutagenesis, cells have developed mechanisms of diminishing LINE-1
insertions in the majority of temporal and spatial contexts. Some of these mechanisms
involve interference with the transcription of LINE-1, and other mechanisms occur at a
later stage, regulating LINE-1 at the RNA or protein level (Bodak et al., 2014).
1.3 Structure of LINE-1 elements and their encoded proteins
Transposition-competent LINE-1 elements are roughly 6-7 kb in length (Scott et al., 1987),
containing a 5’UTR with an internal promoter (Minakami et al., 1992), two open reading
frames (ORFs), and a 3’UTR containing a poly (A) tail (Dombroski et al., 1991). The
LINE-1 ORFs encode two proteins: ORF1p and ORF2p (Scott et al., 1987). These proteins
are required for efficient mobilization of LINE-1 elements (Moran et al., 1996). Despite
their similar names, the encoded proteins are quite different from one another.
ORF1p is an approximately 40kDa protein possessing RNA binding and chaperoning
activity (Kolosha and Martin, 2003; Martin and Bushman, 2001). The protein binding of
LINE-1 RNA to ORF1p is a necessary step of retrotransposition (Kulpa and Moran, 2005).
ORF2p is a larger protein (150kDa) that possesses both endonucleases (Feng et al., 1996)
and reverse transcriptase activities (Martin, 2010; Mathias et al., 1991). The activities of
both proteins are required for LINE-1 mobility.
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1.4 LINE-1 retrotransposition: how does it work?
Active LINE-1 retrotransposition requires the transcription of a full-length RNA molecule
from the 5’ internal promoter, which is translated into the proteins ORF1p and ORF2p in
the cytoplasm (Alisch et al., 2006; Moran et al., 1996). The LINE-1 mRNA is then capable
of binding the translated proteins, forming a ribonucleoprotein (RNP) complex with their
respective proteins. This RNP is then imported into the nucleus, where it initiates reverse
transcription at the target site with a process called target-primed reverse transcription
(TPRT) (Luan et al., 1993). As previously eluded to, most LINE-1 elements present in the
mammalian genome are immobilized. This is because of poor processivity during the
reverse transcription step or potentially because of post-transcriptional and posttranslational LINE-1 RNA degradation.

1.5. LINE-1 Promoter
Although the mouse and humans LINE-1s share similar ORFs, they differ markedly within
the 5′ UTR sequence. This difference is believed to be responsible for the differences in
transcriptional activities in these two species (Severynse et al., 1992). Particularly, the 5′UTRs of the full-length human LINE-1s carry two types of internal promoters, namely
sense and antisense (Hancks & Kazazian, 2012). In contrast, 5′-UTRs of the full-length
mouse LINE-1s contains a sequence of 200 bp. These tandemly repeated sequences are
known as monomers (Severynse et al., 1992). The number of the monomer repeats may
vary among the individual mouse LINE-1 families, where the copy number is linked with
the LINE-1 transcriptional activity (Severynse et al., 1992; DeBerardinis et al., 1999).
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Moreover, the monomers are used to subclassify LINE1 into different subfamilies, and
their presence or absence generally determine which transcription factors (TFs) would
regulate the transcription of these elements. For instance, the promoter of the murine Tf
subfamily binds to the YY1 (YY1 Transcription Factor) factor, whereas the TA subfamily
does not conserve this region (Severynse et al.,1992). That again suggests that the promoter
activity pattern may vary in between the subfamilies and species.
1.5.1 Sense promoter
The first 100 base pairs of the 5′- UTR carries an internal sense promoter. This is essential
for transcription initiation (Swergold 1990). However, this region shows high variability.
In other words, this is very poorly preserved regions in mammals (Zimmerman, 1997;
Eppig et al., 2012). Additionally, this exhibits a frequent stop codons and a high GC content
(˃50%) in comparison to the rest of the LINE1 sequence (Aporntewan & Mutirangura,
2011, Eppig et al., 2012). These features suggest that this region’s function could be
controlling the LINE1 transcription (Aporntewan & Mutirangura, 2011; Eppig et al.,
2012).
1.5.2 Antisense promoter
Besides the transcription of the forward LINE-1 RNA, LINE-1 elements also have
antisense promoters that can drive the expression of nearby genes. The antisense promoter
is found in the 5’UTR (Speek, 2001) of a LINE-1 element. The transcribed mRNA
transcripts (initially discovered in 2001) were chimeric, containing a 5’UTR from LINE1, and exons from the nearby genes. Subsequently, almost 1000 antisense transcripts were
identified in a comprehensive computational study (Criscione et al., 2016). Some of these
chimeric transcripts were also found to be unique to (or, up-regulated in) cancer cell lines
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(Cruickshanks and Tufarelli, 2009; Weber et al., 2010). More recent studies have
implicated LINE-1 antisense promoter in regulating the tissue-specific expression of long
non-coding RNAs (Chishima et al., 2018). A large number of these chimeric transcripts
present in the mammalian genome could reflect a global mechanism for regulating lineagespecific transcription programs. This is consistent with other studies suggesting LINE-1
elements can have regulatory functions in the mammalian genome (Elbarbary et al., 2016).
1.6 Regulation of LINE-1 expression
The expression of LINE-1 elements in mammals is tightly controlled, protecting their
genomes from deleterious effects of random integrations. Initial work suggested that the
transcription of LINE-1 was restricted to the pluripotent cells of the primordial germline
and in embryonic development (Garcia-Perez et al., 2007; Martin and Branciforte, 1993;
Ostertag et al., 2002; Packer et al., 1993; Trelogan and Martin, 1995) where a global wave
of epigenetic remodelling that occurs during embryogenesis allows them to become
upregulated. However, more recent evidence discussed above suggests that their regulation
is complex, multifaceted and that they can be expressed in somatic cells.
1.6.1 LINE-1 and chromatin landscape
An important layer that governs the regulation of mammalian gene expression is
epigenetics and chromatin structure. Epigenetics refers to covalent modifications to the
DNA and the associated proteins (chromatin) that do not modify the actual DNA sequence.
Despite the lack of changes to the underlying DNA sequence or transcription factors, the
effects of these modifications on gene activity and function can be profound (Mazzio and
Soliman, 2012).

7

LINE-1 elements are no exception to this rule: a powerful tool for regulation of LINE-1
expression is through modulating the surrounding chromatin environment (Jachowicz and
Torres-Padilla, 2016). One of the most studied mechanisms by which a repressive
chromatin landscape can silence LINE-1 elements is through DNA methylation.
1.6.2 DNA methylation
DNA methylation is the direct modification to the DNA sequence, through the deposition
of a methyl group at the 5’ carbon on the cytosine base (5mC). In the mammalian genome,
this mark is primarily found at cytosine bases in the context of a CpG dinucleotide (Klose
and Bird, 2006). DNA methylation is enzymatically catalyzed by a class of enzymes called
DNA methyltransferases. These enzymes either act upon an unmethylated DNA strand,
depositing de novo DNA methylation or act upon a hemimethylated transcript to maintain
DNA methylation patterns after DNA replication. DNMT3A and 3B are the de novo
methyltransferases, DNMT1 is the maintenance methyltransferase that faithfully
recapitulates DNA methylation following semi-conservative replication (Edwards et al.,
2017).
DNA methylation is broadly associated with the repression of transcription; however, its
precise relationship with gene activity is more complex than initially recognized. One
genomic context in which its repressive role is less controversial is in the silencing of
transposable elements (Arand et al., 2012; Jones and Takai, 2001; Walsh et al., 1998).
DNA is typically hypermethylated at the promoters of LINE-1 elements in mammalian
cells (Meissner et al., 2008). This DNA methylation is thought to have important functional
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consequences because in mouse embryonic stem cells lacking any active DNA
methyltransferase enzymes, the transcription of LINE-1 is elevated (Tsumura et al., 2006).
1.6.2.1 DNA methylation in development
The role of DNA methylation in silencing LINE-1 elements is certainly significant in
somatic tissues (Arand et al., 2012). The findings of various studies have indicated that
DNA methylation has a complex relationship with LINE-1 activity, with cell-type-specific
regulatory mechanisms. Further complicating this, it is the evidence that the regulation of
LINE-1 elements by DNA methylation could be locus-specific (Philippe et al., 2016;
Vafadar-Isfahani et al., 2017). Historically, studying individual LINE-1 elements has been
technically challenging, but it has recently been shown that in some cases, DNA
methylation at LINE-1 promoters does not correlate with their expression (VafadarIsfahani et al., 2017). The locus-specific activity of LINE-1 elements was also analyzed in
cancer cells in a report published in 2016. Researchers observed that the majority of
transpositionally active LINE-1 elements (the youngest and human-specific LINE-1
subfamily, LINE-1HS-Ta) were transcribed from a few cell-type-specific loci (Philippe et
al., 2016). The researchers found that in their cancer cell lines where they detected LINE1HS-Ta, the general mechanisms regulating LINE-1 activity were not perturbed. This
suggests that locus-specific and cell-type-specific regulatory mechanisms for LINE-1
repression exist in distinct cellular contexts, and that heterogeneity can exist in an already
tightly controlled and multifaceted system.
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1.6.3 Histone modifications
Another mechanism of epigenetic regulation of transcription is through the posttranslational modification of histone tails, a powerful regulator of chromatin structure and
gene expression (Bannister and Kouzarides, 2011). Histone tails can be modified at several
amino acid residues by the addition of small chemical groups, with the most common being
methylation, acetylation and phosphorylation. The resulting landscape of histone
modifications regulates the structure and function of chromatin, fine-tuning gene
expression profiles in a different cell type- and locus-specific contexts. The trimethylation
of lysine 9 on histone H3 (H3K9me3) is most commonly associated with the silencing of
repetitive sequences and transposable elements (Karimi et al., 2011).
Interestingly, H3K9me3-mediated LINE-1 silencing was found to be restricted to mouse
embryonic stem cells. In lineage-committed cell types, DNA methylation was observed at
the H3K9me3-repressed LINE-1 loci, suggesting a shift from histone methylationdependent silencing to DNA methylation-mediated silencing (Walter et al., 2016).
A very recent and comprehensive study aimed to explore the interplay of various chromatin
marks at transposable elements in mouse embryonic stem cells (He et al., 2019). To analyze
the effects of histone modifications on LINE-1 expression, various histone-modifying
enzymes were knocked down and changes in chromosome accessibility and transposable
element expression were assessed. The results revealed that a complex landscape of histone
modifications exists at LINE-1 elements. While the authors acknowledge that definitively
mapping chromatin marks at LINE-1 sequences is difficult owing to their abundance and
sequence identity, they find various histone marks enriched at LINE-1 elements including
H4R3me2, H3K4me1, H3K27ac, H3k9me3 and others (He et al., 2019). These histone
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marks were overlapping and associated with changes to chromatin accessibility. This can
be assayed by a technique called as Assay for Transposase-Accessible Chromatin followed
by sequencing (ATAC-seq), and gene expression programs. This study highlights the
complexity of the epigenetic regulation of these elements and suggests that much of the
role of epigenetic systems in the cell is to manage the expression of mobile DNA.
Besides the transcriptional regulation of LINE-1 with the epigenetic regulation, several
posttranscriptional, translational, and even posttranslational regulations of LINE-1
elements are also involved to restrict LINE-1 mobilization in the mammalian genome.
1.7 LINE-1 activity in the development
LINE-1 expression during development has been a particularly important area of research.
The dynamic remodeling of the transcriptional and epigenomic landscapes during the
transition from pluripotency to the acquisition of lineage commitment affords LINE-1
elements an opportunity for upregulation and activity.
Initial understanding of LINE-1 activity led to the belief that LINE-1 elements were only
expressed in vivo in the early stages of mammalian embryogenesis, or during the
specification of primordial germ cells (precursors of the gametes). Later, retrotransposition
assays showed LINE-1 expression and retrotransposition can occur in a variety of somatic
cell types, and also in vitro culture models, including neural progenitor cells, cancer cell
lines and other mammalian cell culture contexts (Muotri, 2016). LINE-1 expression and
mobilization have been studied extensively both in vivo using mouse models and tissue
samples, and in vitro using cultured cell assays.
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1.7.1 Evidence of LINE-1 expression in vivo during development
The historical view of LINE-1 retrotransposition is that LINE-1 elements are only active
during embryogenesis and malignant transformation. This was challenged by the finding
that LINE-1 retrotransposition can occur in various cells of the brain, and LINE-1 mRNA
and proteins have been detected in various adult somatic tissues (Belancio et al., 2010;
Richardson et al., 2014). The activity of LINE-1 in somatic tissues and disease contexts
will be discussed in detail in later sections.
LINE-1 activity during development in vivo must be tightly regulated to prevent genomic
instability and the accumulation of mutations. This is particularly important during
development, where the genome undergoes rapid and dynamic remodeling, associated with
more permissive chromatin states (Seisenberger et al., 2013). These permissive states are
associated with genomic activation, and LINE-1 expression must be kept in check to ensure
the cell retains control of its activity. The control of LINE-1 is particularly important in
germ cells, where any new LINE-1 insertions will be passed on to the next generation.
LINE-1 expression must be controlled in the pre-implantation embryo, which represents
another crucial period of epigenomic remodeling.
Endogenous LINE-1 elements are expressed at various points in the mouse embryo
(Jachowicz et al., 2017; Packer et al., 1993; Veselovska et al., 2015; Watanabe et al.,
2008). LINE-1 expression has also been shown to be abundant in the two-cell stage
(Fadloun et al., 2013), and decrease over embryonic time between the 2 and 8 cell stage.
The presence of these transcripts has been shown by Northern blot (Packer et al., 1993),
RNA Fluorescence in Situ Hybridization (FISH), and reverse transcriptase-polymerase
chain reaction (RT-PCR) (Fadloun et al., 2013).
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LINE-1 mRNA and protein are expressed in the germline in human and mouse cells
(Peaston et al., 2004; Trelogan and Martin, 1995). However, to prevent their overactivation and the disruption of genome integrity by these elements, they are tightly
controlled by various means. In the germline, specific proteins exist to posttranscriptionally regulate LINE- activity. These proteins (termed PIWI proteins) are
discussed in detail in a later section. Without the regulatory effects of these proteins, LINE1 transcripts accumulate in the testes of adult male mice, but not in wild type mice. This
was shown using in situ hybridization as well as RT-PCR detecting mRNA transcripts
(Aravin et al., 2007; Carmell et al., 2007).
1.8 LINE-1 in the embryo, somatic tissues, and disease contexts
1.8.1 Expression of LINE-1 in the embryo
Endogenous LINE-1 elements are highly expressed in the mouse embryo (Jachowicz et al.,
2017). LINE-1 elements are transcribed soon after fertilization (Fadloun et al., 2013).
Transcription is highest at the two-cell stage and is rapidly reduced after the blastocyst
stage of development. Interestingly, this is (at least initially) primarily attributable to a loss
of activating marks, rather than a gain of repressive marks (Fadloun et al., 2013). LINE-1
expression is higher in the in vivo embryo than in cultured mouse embryonic stem cells
(Jachowicz et al., 2017). This could potentially be explained by the increase in DNA
methylation in cultured cells relative to the cells of the inner cell mass (Ficz et al., 2013).
Importantly, activation of LINE-1 elements during development does not appear to merely
be a consequence of spurious activation because of epigenome remodeling. It has been
shown that inhibiting LINE-1 expression before the two-cell stage interferes with the
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development of the embryo, reducing developmental progression (Jachowicz et al., 2017).
LINE-1 elements have been implicated in modulating the wide-spread changes in
chromatin organization observed during early mouse development (Jachowicz et al.,
2017). This suggests that LINE-1 expression has genuine roles in normal mammalian
biology and the mRNAs are not simply problematic transcripts that are only activated when
silencing mechanisms are perturbed. Recently, Percharde et al. revealed that in mouse
embryonic stem cells (ESCs) and also in pre-implantation embryos, LINE1s have a critical
role in directing the self-renewal capability, transcriptional regulations and also overall
developmental potency (Percharde et al., 2018).
1.8.2 Germ cell expression of LINE-1
An important finding in the past let us believe that mutagenesis mediated by transposable
elements may occur in the germline of humans. In that event, CYBB gene was inserted by
LINE-1 most likely during meiosis I of maternal primary oocyte genome of a male patient
with a chronic granulomatous disease (Boruha et al., 2002). From then onwards, it is well
established now that transpositional events in the germline might be a major source of
genomic variations and diseases in the human population. In that case, the most active
transposable elements: Alus, LINE-1s and SVAs are carrying out the events of reshaping
the genomic landscape of haploid cells and at the same time causing different rare genetic
diseases. It is noteworthy here that these reshaping events not only include insertional
events but also include the deletions of the host DNA sequence (Gilbert et al., 2002).
The exact timing of the endogenous de novo retrotransposition in human germline
remained unclear. A recent study with mouse model indicates that heritable de novo
insertions might start to take place as early as prior germline specification in mammals. In

14

that study, a new LINE-1 insertion was found in 3-5% of offspring, whose both parents
had no such insertion in somatic cells, but the male parent had <1 copy insertion per cell
in both testicles (Richardson et al., 2017). That result indicated that new LINE-1 insertion
in germline-restricted mosaic male parent took place, most likely, in early primordial germ
cells (PGCs) before they colonize genital ridges to form testicles anytime during E10.5E12.5 (Ewen et al., 2010). Due to ethical considerations, the option of proving this notion
of human PGC development is limited.
1.8.3 LINE-1 in somatic cells
Initially, human somatic LINE-1 retrotransposition events were thought to be relatively
rare. However, more recent studies have shown that LINE-1 expression and mobilization
occurs in a variety of somatic cells, for example in tumors (Burns, 2017), and interestingly,
in various tissues of the brain (Goodier, 2014; Suarez et al., 2018).
1.8.4 LINE-1 in the brain
Among the somatic organ systems, the brain has emerged as one of the most active sites
for retrotransposition during development. It is thought that a certain level of
retrotransposition might be advantageous for neuronal development by promoting genomic
diversity. On the other hand, excessive expression or retrotransposition could have
deleterious effects on neural functions.
Retrotransposition in the mammalian brain was first demonstrated in the laboratory mouse.
In 2005, the Gage lab identified new retrotransposition events in many regions of the mouse
brain (Muotri et al., 2005). The insertions were initiated from a human LINE-1-based
transgene and seemed to occur only in neurons but not in oligodendrocytes and astrocytes
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during embryonic and adult neurogenesis. LINE-1 ORF1p was also detected in several
regions of the brain, including the ventricular zone and the dentate gyrus of the
hippocampus. In 2009, the same group showed variable but significant levels of increase
in endogenous LINE-1 copies in multiple regions of human brain samples (Coufal et al.,
2009). Subsequently, two separate groups were able to confirm somatic LINE-1 insertions
in the human brain at the sequence level (Baillie et al., 2011; Evrony et al., 2012). Together
these studies established the brain as a hub for active retrotransposition in humans and
heralded a new era of investigating the extent of somatic mosaicism in the brain and its
functional implications.
How frequently does LINE-1 retrotransposition occur in a human brain? The answer to this
question is complicated by both the methodology used and the inherent variation in
retrotransposition. Using quantitative PCR on bulk samples the initial report suggested an
increase of 80 copies of LINE-1 per cell in the hippocampus (Coufal et al., 2009). The
figure was later refined by two studies employing advanced single-neuron sequencing
analyses. The Walsh lab estimated up to 1.1 somatic LINE-1 insertions per cortex and
caudate neurons (Evrony et al., 2012). The Faulkner lab’s estimation was an average of
13.7 new insertions per hippocampus neuron (Upton et al., 2015). The discrepancy
between these two studies likely originated from technical variations in sequencing
approaches, data analytics and validation methods (Evrony et al., 2016). Indeed, factoring
the most stringent validation criteria into the calculation, the frequency of unique LINE-1
insertions may be as low as 0.04 or 1 in every 25 neurons (Evrony et al., 2012). The
variation in estimated retrotransposition frequencies does not necessarily diminish the
potential functional impact of such insertions. If we assume 0.04 insertions per neuron as
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the tangible minimum, there will still be approximately 3.4 billion unique somatic
insertions among 86 billion neurons in a typical adult human brain! Also, somatic
retrotransposition is variable in different individuals as well as in different regions of the
brain.
Information about the developmental timing of LINE-1 retrotransposition in the brain
remains scarce. Nevertheless, important insights have been gained from lineage tracing
analysis of two somatic LINE-1 insertions in a normal human brain (Evrony et al., 2015).
One insertion was distributed over the entire left hemisphere and present not only in
neurons but also in non-neuronal cells, suggesting that it arose in one of the earliest
progenitor cells of the central nervous system. In contrast, the second insertion was
restricted to neurons at the left middle frontal gyrus, suggesting that it occurred relatively
late during cortical development in the embryo. Unlike the original mouse study, singlecell analyses have also identified somatic LINE-1 insertions in glial cells (Evrony et al.,
2015; Upton et al., 2015; Erwin et al., 2016). Whether differentiated glial cells support de
novo retrotransposition is unknown as many such insertions could have originated in
progenitors common to neurons and glia (Evrony et al., 2015; Upton et al., 2015). Although
it has not been established in vivo, in vitro cell culture experiments have provided a
comparison of neural stems cells, neuronal progenitor cells (NPCs) and terminally
differentiated neurons in their capabilities of supporting retrotransposition. The
overwhelming evidence pinpointed neuronal progenitor cells as the hub for LINE-1
insertional events. Besides, both human and rodent LINE-1 promoters possess overlapping
SOX2/WNT binding sites. In these cells, Sox2 is downregulated as Wnt is upregulated. The
latter activates LINE-1 promoter activity and transcription (Kuwabara et al., 2009).

17

Whether LINE-1 retrotransposition plays a functional role in normal brain physiology is
not yet understood. Given the connectivity of brain cells and the estimated collective
mutational burden in the entire brain, somatic retrotransposition has the potential to exert
a significant impact on neuronal functions. Of relevance, in both rat NPCs and human
hippocampal neurons, somatic LINE-1 insertions can occur in neuronally expressed genes,
including those that are involved in different synaptic processes (Muotri et al., 2005; Upton
et al., 2015). Notably, besides insertional mutagenesis, LINE-1s can also remodel the
genomic landscape of neurons by inducing large genomic DNA deletions, a process that is
retrotransposition independent (Erwin et al., 2016). In this context, genomic diversity may
beget a functional diversity within the human brain.
On the other hand, excessive LINE-1 mobilization in the brain has been linked to many
neurodevelopmental and neurodegenerative disorders. For example, the rate of LINE-1
retrotransposition was found to be higher in NPCs derived from human tissue of a patient
with Rett syndrome (RTT), a neurodevelopmental disorder due to a mutation in the Xlinked MECP2 gene (Muotri et al., 2010).
1.8.5 LINE-1 in other somatic tissues
LINE-1 mRNA has been detected, although mostly at low levels, in a variety of cell types.
Interestingly, a human retrotransposition assay in mouse models suggests there is no
inherent barrier to LINE-1 protein expression and activity in somatic cells (Ostertag et al.,
2002). A comprehensive study from 2010 studied an array of tissues, finding LINE-1 RNA,
protein, and de novo insertions in most human (somatic) tissues (Belancio et al., 2010).
Whilst specific reports of LINE-1 expression and activity in healthy somatic tissues are
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rare, expression and activity have been noted in cells of the gastrointestinal system as well
as in the esophagus.
In a study investigating Barrets Esophagus and esophageal cancer found that although
LINE-1 retrotransposition events were seldom found in normal tissue, LINE-1 protein
expression was detected in all tissues examined (Doucet-O'Hare et al., 2015). LINE-1
protein expression has also been found in cells closely associated with male germ cells,
such as Sertoli cells and vascular endothelial cells, likely linked to transposition in the
gametes (Ergun et al., 2004).
These reports suggest that whilst the expression of LINE-1 occurs outside of the germline
and neuronal tissues, the level of activity is highly heterogeneous between tissues. Active
retrotransposition is likely inhibited by other means in these cells to prevent the
accumulation of DNA damage.
1.8.6 LINE-1 in disease states
LINE-1 is associated with various disease states (Hancks and Kazazian, 2016). This
includes in the initiation and progression of cancers, autoimmune disorders and Mendelian
diseases.
In the germline, LINE-1 can act as a mutagenic agent through insertional mutagenesis –
disrupting exons and inducing double-stranded breaks (Belancio et al., 2008). This has
been shown as the causative mutation in cases of haemophilia A (Kazazian et al., 1988),
choroideremia (Van den Hurk et al., 2007), β thalassemia (Lanikova et al., 2013) and
various other diseases reviewed (Beck et al., 2011). Interestingly, a high number of these
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disease-causing mutations are found on the X chromosome, potentially implicating
recombination in LINE-1 insertions (Belancio et al., 2008).
LINE-1 insertions can also occur in somatic cells, although these effects are not inherited
by the next generation. LINE-1 over-expression and mobilization has also been associated
with multiple neuropathologies (Bundo et al., 2014; Liu et al., 2016; Suarez et al., 2018;
Tan et al., 2018) and is linked with genomic instability and malignancy in cancers (Burns,
2017).
1.8.7 LINE-1 expression in cancer
LINE-1 protein expression is a hallmark of malignancy (Rodic et al., 2014). LINE-1 hypomethylation, activation and integration is associated with many cancers, often correlated
with poor prognosis. LINE-1 integration can be a source of genome instability through
inducing DNA damage, insertional mutagenesis and chromosomal rearrangement. The
dysregulation of LINE-1 elements, often by hypomethylation, can contribute to the
pathogenicity of tumors (Briggs et al., 2018; Burns, 2017; Carreira et al., 2014; Schulz,
2006; Doucet-O'Hare et al., 2015; Miki et al., 1992; Kerachian and Kerachian, 2019; Rodic
et al., 2014). Certain tumor types are more prone to LINE-1 retrotransposition (Table 1.1).
For example, tumors of the gastrointestinal tract (Lee et al., 2012; Solyom et al., 2012), as
well as hepatocellular carcinomas, prostate and ovary cancers. These retrotransposition
events usually correlate with LINE-1 mRNA and protein expression, suggesting that
mechanisms to diminish LINE-1 expression have been compromised (Burns, 2017; Rodic
et al., 2014). The activity of LINE-1 in cancer pathogenesis is heterogeneous; sometimes
LINE-1 expression and insertions are early events in tumorigenesis (Scott et al., 2016;
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Tubio et al., 2014), in other cases, they accumulate in downstream events, likely as an
effect of better conditions for LINE-1 expression to occur (Burns, 2017).

Table 1.1: Classification of cancers in human based on somatic retrotransposition
activity (adopted from Saha & An, 2019).

1.9. Tools for studying mammalian LINE-1 retrotransposition
Studying mobile elements has been historically challenging. This is due to their abundance
in the genome, repetitive sequences, and the accumulation of polymorphisms. However,
the development of cleverly designed reporter systems as well as an adaptation of classic
molecular biology techniques and advances in sequencing technology have produced a
range of tools for use in studying LINE-1 biology. Some of these tools and methods are
discussed below.
1.9.1 LINE-1 retrotransposition reporter constructs
The first published cultured cell LINE-1 retrotransposition assay in 1996 represented a
significant advance in the field, as it allowed retrotransposition to be studied in real-time
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(Kopera et al., 2016; Moran et al., 1996). The rationale behind this assay is the integration
of a reporter construct that is only detectable when a LINE-1 element is transcribed, reverse
transcribed, and integrated elsewhere in the genome. A retrotransposition indicator cassette
is integrated into 3′-UTR of LINE-1, in the opposite direction of LINE-1 transcription. This
cassette consists of a reporter gene sequence, which is interrupted by an intron which is
transcribed in the same direction as the LINE-1 mRNA. The reporter construct can only be
expressed when transcription occurs from the LINE-1 promoter, which splices out the
intron from the reporter cassette, resulting in reverse transcription of LINE-1 RNA and
the integration of new copies of the LINE-1 sequence as well as the reporter cassette into
the genome. The cells possessing a successful integration can be selected based on the
presence of the reporter construct, and researchers now have a set of tools to analyze LINE1 activity (Kopera et al., 2016; Moran et al., 1996).
Several adaptations of this assay have permitted various studies on LINE-1 activity in a
range of systems (Rangwala and Kazazian, 2009). This includes studies of LINE-1
retrotransposition in the neural progenitor cells (Coufal et al., 2011; Coufal et al., 2009),
non-dividing primary human cells (Kubo et al., 2006) and the generation of a mouse model
(Ostertag et al., 2002). Important regulatory questions have also been investigated using
derived assays, including the epigenetic silencing of the LINE-1 retrotransposition (GarciaPerez et al., 2010), and the cellular kinetics of retrotransposition (Ostertag et al., 2000).
However, concerns are there regarding the robustness of these tools which may bring about
variables between the assays to cause the misinterpretation of the results (Cook and Tabor,
2016).
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1.9.2 Studies in cultured cells
Embryonic stem cells are a frequently used model for studying the regulation of molecular
events and the role of different regulatory factors. This is a result of the plastic genome of
pluripotent cells and the ability of these cells to transition into a variety of different cell
types in culture. Embryonic stem cells are of particular interest in the field of LINE-1
biology, as LINE-1 transcripts, as well as active LINE-1 transposition, are frequently
detected in these cells (Garcia-Perez et al., 2007).
Using induced pluripotent stem cells (iPSCs) from human neonatal dermal fibroblasts, it
has also been shown that LINE-1 expression is elevated during reprogramming from the
somatic cell to the induced pluripotent state. This activity resulted in low-level insertions
of LINE-1 elements (Arokium et al., 2014). This study could be of importance to the iPSC
field, as it cautioned researchers about potential genotoxic effects that occur during somatic
cell reprogramming.
1.9.3 Mouse models
To better understand human LINE-1 retrotransposition, Ostertag and colleagues generated
a transgenic mouse model, in which eGFP is conditionally expressed in the spermatocytes
through a spermatozoa-specific preproacrosin promoter (Ostertag et al., 2002). A
functional eGFP is only produced when a retrotransposition event has occurred (Moran et
al., 1996). This is because the eGFP cassette contained an antisense γ-globin intron that
cannot be spliced out. However, when the cassette is cloned into the LINE-1 3’UTR, in an
antisense orientation, retrotransposition can remove the antisense intron and produce a
functional eGFP (Moran et al., 1996; Ostertag et al., 2002; Ostertag et al., 2000). Using
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this system, researchers discovered that one de novo insertion was occurring in every 70
sperm for mice in the germ cells of mice. Although, later An et al found that the mutagenic
effect of LINE-1 insertions was relatively high as 1 insertion per 3 sperms using CAGORFeus transgenic mouse line (An et al., 2006). Mouse models have also been utilized to
show that integration events occur more often in embryogenesis than in the germ cells,
generating somatic mosaicism (Kano et al., 2009).
1.9.4 High throughput sequencing
Technical challenges are put forward by the sequence abundance of LINE-1 and their
polymorphism in the genome for their detection. To circumvent these issues, more
advanced methods of high throughput sequencing have been implemented to study the
expression, regulation and activity of LINE-1 elements in the genome (Xing et al., 2013).
For example, Retrotransposition Capture Sequencing (RC-seq) (Baillie et al., 2011;
Sanchez-Luque et al., 2016), which is a method that enriches sequencing libraries for
retrotransposon insertions. RC-seq achieves this using biotinylated capture probes, which
target the 5’ and the 3’ end of the LINE-1 consensus sequence. This reduces the level of
PCR amplification required and limits biases associated with normal genome-wide
sequencing of rare genomic elements, such as heterogeneous retrotransposition events.
1.9.5 In vitro biochemical assays
In vitro biochemical assays have also been valuable in providing insights into LINE-1
function (Viollet et al., 2016). These have been focused on detecting the retrotransposition
activity of ORF2p.
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The LINE-1 Element amplification Protocol (LEAP) enables researchers to assess the
ability of ORF2p to reverse transcribe LINE-1 mRNA in vitro using the purified LINE-1
RNP from human cells harboring LINE-1 expression constructs (Kopera et al., 2016;
Kulpa and Moran, 2006; Viollet et al., 2016). The assay involves the transfection of cells
with constructs expressing differentially tagged ORF1p and ORF2p. The RNP complexes
are purified from cells by centrifugation or immunoprecipitation. The RNP is then
incubated with an oligonucleotide (termed as LEAP adapter) to prime cDNA synthesis.
The LINE-1 cDNAs are the PCR-amplified primers complementary to the adapters and the
LINE-1 construct. The PCR products can then be visualized and characterized (Kopera et
al., 2016). This assay has been used to investigate the process of target-primed reverse
transcription. The direct LINE-1 extension assay (DLEA) is a similar assay with an
alternative design to detect reverse transcription of LINE-1 mRNAs. DLEA involves the
incorporation of a radiolabeled nucleotide before primer elongation (Monot et al., 2013;
Viollet et al., 2016).
ORF1p, is one of the proteins essential for retrotransposition, is expressed in large extents
in the cellular cytoplasm. These proteins can also be targeted with monoclonal antibodies
as a robust indicator of LINE-1 expression in cells or tissues (Sharma et al., 2016).
1.10 Detection of LINE-1 expression
Studies of retrotransposons have been largely hindered by their repetitive and abundant
nature. This makes amplification, detection and sequencing of these regions challenging.
1.10.1 Protein-based detection: One way to study LINE-1 activity in terms of its
expression and localization is through classical detection methods, such as immuno-based
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assays. This typically involves using an antibody against ORFP2. Whilst this is a robust
method, it will not detect LINE-1 elements that are transcribed into RNA but not translated
into proteins. Therefore, it does not take into account the post-transcriptional regulation of
LINE-1 transcripts. (Sharma et al., 2016). However, it is a useful method for detecting
protein levels as well as localization at a single nucleus level.
1.10.2 Nucleic acid-based detection: First, RNA-FISH is a technology that is useful for
detecting LINE-1 expression, as it also benefits from single nucleus resolution (Jachowicz
et al., 2017). However, the advantage of RNA-FISH over immune-detection methods is
that nascent transcripts are assayed, meaning transcription is more directly measured. On
the other hand, LINE-1 insertion events have also been tracked with DNA FISH, detecting
retrotransposition patterns using a LINE-1/neomycin vector, which is only detectable using
FISH probes when the Neomycin gene has been reverse transcribed as a result of LINE-1
activity (Bojang and Ramos, 2016). Microscopy can also be implemented finally to both
of these approaches to analyze the LINE-1 expression.
Northern blot analysis remains the most traditionally used and reliable technique to detect
LINE-1 transcription which uses probes complementary to LINE-1 RNA (Deininger and
Belancio, 2016). The probes can be designed to detect particular sub-types of LINE-1
elements, such as full-length LINE-1 elements or the discrimination between sense and
antisense transcripts (Deininger and Belancio, 2016).
1.11 Concluding remarks
While initially transposable elements were thought merely to be marks of parasitic
infection, it is becoming increasingly clear that they play fundamental roles in mammalian
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biology. LINE-1 elements, in particular, are a crucial part of the mammalian genome.
Understanding the tight control of their expression patterns as well as their function in
normal and diseased cells is a question of utmost importance in the fields of epigenetics,
transposon biology and developmental biology.
The huge abundance of LINE-1 elements in the human and mouse genomes, repetitive
nature and complex expression patterns requires the development of innovative
technologies and the careful design of experimental procedures used to study these
elements. With the advancement of these tools, we have learned of the multi-layered
regulation of these elements at all layers of their expression and mobility, and we have
discovered novel functions of transposable elements. Aside from their clear roles in
shaping the landscape of the mammalian genome, it appears that cells have evolved ways
to utilize LINE-1 expression and retrotransposition.
The mechanism and purpose of fine-tuned LINE-1 expression during embryogenesis has
been a frequently asked question. Recently, researchers have made progress in answering
such questions; LINE-1 elements appear not to be an unfortunate side-effect of epigenetic
remodeling but are required for the normal development of the embryo (Jachowicz et al.,
2017). The implication of LINE-1 elements in such crucial processes along with the
emerging theme of their context- and locus-dependent expression (He et al., 2019) patterns
are likely to have a huge impact on the future of the field.
1.12 Objective of the current project
Retrotransposons belong to a class of mobile genetic elements that comprise 43% of the
human genome (Lander et al., 2001). Long interspersed elements type 1 (LINE-1s) are the
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most abundant retrotransposon, accounting for 17% of the human genome. The human
genome is impacted by retrotransposons in multiple ways (Goodier and Kazazian, 2008).
Insertional mutagenesis is the most noticeable form of alteration and has been observed in
more than 100 cases of human diseases, including cancer and birth defects (Hancks and
Kazazian, 2016). The majority of LINE-1s became immobile during the course of
evolution. Although LINE-1s more retrotranspose in the germline cycle, some
retrotransposons may also be active in somatic tissues (Belancio et al. 2010; Ergun et al.
2004). It is estimated that among the total number of 500,000 LINE-1s presents in the
human genome, 80-100 LINE-1s remain competent for retrotransposition (Brouha et al.,
2003). LINE-1 insertions can also impact the genome by altering gene expression. A fulllength LINE-1 is typically 6-7 kb and has its promoter located in the 5′ untranslated region
(UTR) (Swergold, 1990). Retrotransposition is only possible when LINE-1 is expressed,
and because LINE-1 transcription is regulated by its 5’UTR promoter, it is essential to
understand the spatiotemporal control of LINE-1 promoter activity. Besides the small set
of retrotransposition-competent LINE-1s, an additional set of 7000 immobile LINE-1s still
carry active promoters, which are capable of producing transcripts (Khan et al., 2006). The
vast number of intact LINE-1 promoters when active may control the expression of proteincoding genes and also can produce chimeric transcripts that might lead to pathogenic
conditions, like cancer. It has also been proposed that activated LINE-1 promoters may
trigger initiation of cancer through epigenetic changes (Wilkins, 2010). Nevertheless, till
today no attempt has been made to profile LINE-1 promoter activities in a locus dependent
manner in vivo. Therefore, this project will employ transgenic mouse model to profile
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locus-dependent LINE-1 promoter activities in various somatic tissues as well as in gonads
throughout different developmental time points.
It is extremely technically challenging to monitor transcriptional activities of individual
endogenous LINE-1s due to high sequence homology. Toward this goal, we generated
single-copy 5’UTR-LacZ and 5’UTR-LacG mouse models. Both LacZ and LacG encode
functional β-galactosidase, which can be visualized by X-gal staining. The LacG reporter
gene lacks CpG dinucleotides, preventing transcriptional silencing via DNA methylation
of the transgene body. After the mapping of the transgene locus in each line, different
tissues from these single-copy transgenic mice were stained with X-gal to visualize LINE1 promoter activity in these tissues. In addition to that, we checked the influence of
different orientations, sense and antisense, of the same endogenous promoter in a specific
locus, Rosa26. Also, we attempted to identify the brain cells holding the transgene
expression.
We found that transgenic expression from two independent transgenic constructs varied
significantly, with LacG lines having high expression compared to LacZ line. Besides
interline, intraline variation was also observed in these two broad classifications. The
kidney and thalamus of the brain were found to be a preferential hub of high promoter
activity in most of the LacG lines. Also, an extreme contrast was observed between these
two gene-targeted sense and antisense lines.
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Chapter 2
Locus-specific LINE-1 promoter activity

2.1 Abstract
LINE-1s are tightly regulated with a different host-defense mechanism in a mammalian
organ system. It is always intriguing how the LINE-1 promoters are regulated in a wide
range of mammalian organs, how active they are through different phases of development,
and what makes them mobilize smoothly or even repressed. It is extremely challenging to
address these question with alive or post-mortem human samples. Therefore, to learn more
about the regulation of the promoter activity, we generated two main transgenic mouse
lines: LacZ and LacG, and also generated their sublines by mobilizing the transgene to
different loci. In combination with an in situ histochemical detection technique (X-gal
staining) aided by an automatic signal detection technique, we screened the main organs
from the animals belonging to three different developmental time points. We found that
LacZ sublines had very fewer signals in comparison to the LacG sublines. LacG071, a
subline of LacG line, showed higher promoter activity in many organs than other sublines.
A closer analysis of the expression pattern of the LacG sublines further elucidated a locusspecific, organ-dependent, and age-linked regulation of LINE-1 promoter activity.
Furthermore, kidney and thalamus were especially found to be as the most preferential
organ and brain region for high promoter activity, respectively.

37

2.2 Introduction
Our understanding of LINE-1 regulation in our genome is limited from the organ- and
locus-specific determinants. The extent of LINE-1 insertional polymorphism and the
abundance of sequence identity in the mammalian genome put a challenge for studying
these elements. Based on the recent evidence at both the RNA level (Philippe et al., 2016;
Deininger et al., 2017) and reinsertion (Tubio et al., 2014), it is clear that only a few
numbers of loci are retrotransposition competent. Therefore, it is high time to quantitate
the locus-specific LINE-1 activity. Many studies adopted qPCR assay due to the ubiquity
of the LINE-1 RNA. However, owing to the repetitive nature of LINE-1 sequences, it is
hard to obtain an accurate, quantitative data based on LINE-1 transcripts. Furthermore, it
is hard for qPCR assay to distinguish between a handful of the retrotranspositioncompetent transcripts in a plethora of non-coding RNAs and truncated LINE-1 transcripts.
This problem, however, can be addressed with implementing a transgenic approach.
Until today, none of the approaches could quantify locus-dependent LINE-1 expression in
situ in transgenic mouse models. Therefore, in this study, we examined the role of
chromosomal location on the expression of endogenous LINE-1 promoter fused with
reporter construct in a wide range of somatic as well as germline organs. To achieve that
we generated single-copy transgenic mice by pronuclear injection, where transgenic
constructs were mobilized into unique random chromosomal sites. The in vivo expression
from some specific LINE-1 loci was assayed by histochemical staining for betagalactosidase activity in a wide range of organs in different mouse developmental time
points.
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2.3 Materials and Methods
Ethics statement
The study was carried out under the strict accordance with the guidelines provided by the
National Institutes of Health in the Guide for the Care and Use of Laboratory Animals. The
protocols were thoroughly approved by the Institutional Animal Care and Use Committees
(IACUC).

Plasmids Construction Details
Plasmid pWA370 contains the 5’UTR-LacZ transgene. It is constructed via a three-way
ligation of the BglII/NotI fragment from pMD002, the NotI/NcoI fragment from pWA125
(Newkirk et al, 2017), and the NcoI/BamHI fragment from pQUEST-nucLacZ (a gift from
Liqun Luo; Addgene plasmid # 24356; http://n2t.net/addgene:24356; RRID:Addgene
24356) (Potter et al, 2010).
Plasmid pWA371 contains the 5’UTR-LacG transgene. It is constructed via a three-way
ligation of the BglII/NotI fragment from pMD002, the NotI/NcoI fragment from pWA125
(Newkirk et al, 2017), and the NcoI/BglII fragment from pAAVf-EnhCB-lacZnls (a gift
from Phillip Zamore; Addgene plasmid # 35642; RRID:Addgene 35642).
Transfection
The MW ratio between pWA370 (5930151.43 Da) and pWA371 (5324719.19 Da) is 1.1
(pWA370/pWA371). To be fair for expression comparison, we adjusted the plasmids
amount to achieve an equal copy number of the plasmids. 880ng pWA370 was mixed with
2.2ul P3000 reagent (Lipofectamine 3000 kit) in 50ul Opti-MEM medium. Similarly,
800ng PWA371 mix with 2.2ul P3000 reagent (Lipofectamine 3000 kit) in 50ul Opti-MEM
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medium. Vortexed shortly two vials of DNA/P3000 mixture with 3.3ul L3000
(Lipofectamine 3000 kit, premix with another 50ul Opti-MEM medium) respectively. For
both plasmids, incubated for 15 minutes under room temperature and aliquots into 3
different wells following titration manner (60ul, 30ul, 10ul) in 24-well plate. Then, added
500ul 3T3 cell suspension (1.2 X 10^5/ml) into corresponding wells which had transfection
complex and gently shook the plate to evenly seed cells. We also included a GFP control
plasmids which had similar size and show good transfection efficiency. Within 3 different
plasmids amount (300ng, 150ng, 50ng), 50 ng was the most the optimal condition which
clearly showed pWA371 (GCless) had significantly higher expression profile, while higher
plasmids amount might saturate the expression and could not be differentiated obviously.
The transfected cells rinsed with 1XPBS and were fixed for 5 minutes in 4C, which was
followed by 2X washing in again 1XPBS at room temperature. Overnight staining was
carried out in staining solution. Fixative contained 2% formaldehyde and 0.2%
glutaraldehyde. The staining solution contained 5mM K-ferricyanide, 5mM Kferrocyanide, 2mM MgCl2, and 1mg/ml X-gal.
Mice
WT and transgenic mouse lines were maintained in the C57BL/6J (B6) background. Mice
were housed in well-ventilated cages. In maximum, up to five adult mice per cage was
allowed. They fed on quality-controlled standard pellet chow and pure water ad libitum in
a regular 12-hour light/dark cycle at room temperature. Wild type variants or C57BL/6J
(B6) were initially purchased from Jackson Laboratory. H1t-SB100X mice were generated
in C56BL/6N background at Max Delbrück Center for Molecular Medicine, Germany.
LacG and LacZ are generated by traditional pronuclear microinjection protocol by Cyagen
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Biosciences Inc., US. Rosa26 sense and Rosa26 antisense lines were produced with gene
targeting (homologous recombination) method by Cyagen Biosciences Inc., US. Z/EG
mice (Novak et al., 2000) (JAX stock 3920) were procured from Jackson laboratory as
well. Mov10l1+/−mice (Zheng et al., 2010) were gifted by P. Jeremy Wang, University of
Pennsylvania, PA, through Phillip Zamore at University of Massachusetts Medical School,
Worcester, MA. Mov10l1+/−mice were crossed with transgene positive animals to generate
Mov10l1 knock out a mouse in two steps of breeding.
Real-time PCR
SYBR-Green I master mix (Applied Biosystems) was used to perform Real-time PCR or
quantitative PCR reactions in triplicate with 10ng cDNA template in 25ul of reaction
volume. Q=E^(Min(mean Ct of all samples)-Ct) formula was used to calculate relative
quantity (Q) of a specific transcript. E and Ct represent mean PCR efficiency and threshold
cycles, respectively. Mouse Gapdh gene was used as internal control, and also no template
controls were included. Following primer pairs were used (Table 2.1).

Transgene
LacG
LacZ

Primers
WA580
WA581
WA574
WA575

Table 2.1 The primer pairs used for the genotyping of the transgenic lines.

Droplet digital PCR
Bio-Rad protocol was followed for running the Droplet Digital PCR (ddPCR) reactions,
containing approximately 60ng of gDNA and fluorescence probe in reaction volumes. Each
well of the reactions contained 60ng of gDNA. Droplet generation step was preceded by a
step of DNA digestion with 10U/ul of NcoI (NEB) at 37C for 15 minutes. An eight-well
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Bio-Rad DG8 droplet generator cassette was used for carrying out droplet generation step.
Each well of this cassette was using 20ul of sample added with 40ul of droplet oil. The
generated droplets underwent through a PCR cycling condition: 95C for10min, (94C for
30sec, 60C for 1min) x 40 cycles, extension temperature of 98C for 10min. QX200 droplet
reader was used to read the fluorescence signals from each droplet. Later, the result was
analyzed with the help of Bio-Rad Quantasoft software version 1.3.2.0. The primers are
listed below in Table 2.1.

Ligation mediated PCR (LM-PCR) & sequencing of the amplicon
Steps in Ivics, et al. 2011, Nature Protocols was used to get the amplicons, using the PCR
reaction protocol described in the table. The DNA sequence was (agarose 1%) get cut and
purified, using QIAquick PCR Purification Kit (QIAGEN). The amplicons were Sanger
Sequenced by Eurofins Genomics. Each sequencing result was visualized with FinchTV
(version 1.4) software for Windows.

BLAST
A basic local alignment search tool (BLAST) or BLAST-like alignment tool (BLAT) was
used to search for the DNA sequence directly flanking the transposon, at the University of
California,

Santa

Cruz

(UCSC)

Genome

Bioinformatics

website

(http://genome.ucsc.edu/cgi-bin/hgBlat) or the National Center for Biotechnology
Information (NCBI) website (http://blast.ncbi.nlm.nih.gov/Blast.cgi).

Genotyping PCR & Locus Specific-PCR (LS-PCR)
Genotyping of the mice was performed with gDNA mainly from their tail biopsies. A PCR
reaction using ExTaq or ExTaq HS polymerase was run for the detection of the presence
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or absence of expected transgene with the set of specific primers designed onto the
respective transgene sequences (Table 2.2a).
Locus Specific-PCR (LS-PCR) or junction PCR uses the primers designed to amplify the
location between the transgene and the genomic DNA. The primers were designed with
MacVector software Table 2.2b. It used the following conditions and PCR protocols to get
the expected band.

Line

Primer pairs

Expected
band

LacZ

WA0570, WA0571

385 bp

LacG

WA0572, WA0573

311 bp

H1T

WA0440, WA0441

200 bp

Z/EG

WA0679, WA0680

173 bp

PCR protocol
Genotyping PCR
C
min/s
3min
94
15sec
94
30sec
57.5
1 min
72
7min
72

35cyl

Table 2.2a Desired length of the amplicon in the genotyping PCR.

Lines
LacG082

Primer pairs to get PCR protocol
the transgenic band
WA0984 - WA0598
LSPCR

Expected bands

LacG221

WA0988 - WA0598

LSPCR

500bp

LacG061

WA0980 - WA0598

LSPCR (with 60.5C
annealing temperature)

1200bp

LacG071

WA0649 - WA0598

LSPCR touchdown

500bp

LacG141

WA1529 – WA0598

LSPCR

508bp

510bp

Table 2.2b The PCR protocols used and the expected bands for different sublines.
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PCR protocols
Types
LSPCR PCR
Cycle #
Denature
1
2-31
32

94°C, 5 min
94°C, 1 min

Protocols
Anneal

Extend

55°C, 30s

72°C, 30s
72°C, 7 min

33
LSPCR touchdown
Cycle #

Denature

1

94°C, 5 min

2-11
12-36
37

Hold

4°C
Anneal

Extend

94°C, 1 min

65°C, -1°/cycle, 30s

72°C, 30s

94°C, 1 min

55°C, 30s

72°C, 30s
72°C, 7 min

38

Hold

4°C

LMPCR 1
Cycle #

Denature

Anneal

Extend

1

96°C, 2 min

2-11

92°C, 40s

60°C, -1°/cycle, 40s

72°C, 2 min

12-36
37

92°C, 40s

50°C, 40s

72°C, 1 min
72°C, 10 min

38
LMPCR 2

Hold

4°C

Cycle #

Denature

Anneal

Extend

1
2-7

96°C, 2 min
92°C, 40s

60°C, -1°/cycle, 40s

72°C, 1 min

8-21
37

92°C, 40s

59°C, 40s

72°C, 1 min
72°C, 10 min

38

Hold

4°C
Table 2.3 Essential PCR protocols (adopted from Ivics et al., 2011).

gDNA Isolation
In general, for genotyping, gDNA was isolated from tail biopsies, using the Gentra
PureGene Tissue Kit (Qiagen). Mouse tissues were collected from animals between 1 week
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–18 months of age, and a section of all trimmed organs, from the mice of all ages, was
always kept stored in RNAlater (Sigma) for methylation analysis or DNA needed for
ddPCR. The gDNA from these tissues (weighing, 10mg) was extracted using either
DNeasy Blood & Tissue Kit (Qiagen). In some cases, where extracting gDNA from the
paraformaldehyde tissues was essential, after cell lysis step, the lyse was further treated in
the high heat of 95C for 30 minutes to break the peptide cross-linkages before using it for
further steps of Gentra PureGene Tissue Kit (Qiagen).

Tissue harvesting and preparation
Animals were euthanized with isoflurane. Immediately after the respiratory arrest, the
diaphragm was cut to expose the liver. Later, the diaphragm was first to cut laterally across
and again cut on both ends of diaphragm across the ribs and towards the head to expose
the heart. A needle of the winged infusion set (19 Ga) connected to a peristaltic pump with
a tube inserted the catheter needle into the protrusion to extend up approximately 5mm
inside the ascending aorta. The right ventricle of the heart was cut open with a sharp scissor
for drainage of blood. First, 1× PBS flowed slowly but constantly until the liver got pale.
Next, the fixative used to perfuse the heart. Neonatal animals were perfused with 18ml of
either 1XPBS or 4% PFA without additives (duration: 3min; flow rate: 6 ml/min), and the
adult and aged mice were perfused with 36ml of either 1XPBS or 4% PFA without
additives (duration: 4min; flow rate: 9 ml/min).
Next, the organs were individually collected into cold 1XPBS for clearing of any blood.
The organs, except the brain, were then trimmed according to the desired orientations
(Table 2.4) mentioned in the work by Ruehl-Fehlert et al. in 2003 (Ruehl-Fehlert et al.,
2003). Next, the tissues were drop-fixed into 2% PFA with additives for neonatal organs
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for 4 hours or into 4% PFA with additives for neonatal organs for 6 hours under constant
agitation. Later, washed for 40min in 1XPBS for 2 times (each for 20min). Dropped into
15% sucrose solution at 4C until they dropped. When dropped again put into 30% sucrose
solution until they dropped again. The organs were soaked for the water out and were
equilibrated in OCT not more than 15 - 20 mins. The tissues were then rightly oriented,
being in steel made tissue embedding molds, before snap freezing in liquid nitrogen. The
snap freezing was carried on an iron/steel base immersed into liquid nitrogen and with the
OCT molds placed onto the base. The OCT blocked were packed in zip bags individually
and stored at -80C until use.
Organ
Brain

Localization
Sagittal

Heart

Through ventricles and atria

Lung

Left lobe

Liver

Left lateral lobe

Kidney
Spleen

Through the tip of the papilla and renal
pelvis
At largest extension

Testis

Close to rete testis

Direction
Longitudinal
Longitudinal
Longitudinal horizontal
Transverse
One-side longitudinal
Transverse
Longitudinal

Table 2.4 Organ-specific orientations used during the trimming of the tissues.
Cryosectioning and X-gal staining of fixed tissue
Before beginning, it was made sure that the OCT blocks are at -20C at least 20-30 minutes
before sectioning. Tissues were sectioned in a thickness of 20um for X-gal staining and
14um for immunostaining. The microscopic slides were dried in air for 15-20 minutes. The
slides were washed in 1X PBS for 5min at 4C, incubated in 1% PFA solution for 5 minutes
at 4C, and left in 1XPBS at 4C until next step. Washed with freshly prepared LacZ wash
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solution for 15-20 minutes on a rocker. Incubated for overnight (14-16 hours) for all lines
(except, Rosa26 antisense line and slides for subsequent immunostaining) or at 37C, being
immersed into freshly prepared X-gal solution (adjusted to required pH) with a casual
covering. Took the slides out of the incubator. Rinsed with water. Washed for 20 min in
total in 1XPBS (2 times for each 10 min) under agitation. Post-fixed in 1% PFA for 5 mins
in RT. Washed with 1XPBS for 10 mins. Rinsed with water. Counterstained with freshly
prepared neutral red for 7 min with intermittent shaking. Rinsed with water. Dehydrated
for 3 mins each in 70%, 90%, 100% ethanol. Dried shortly and add EcoMount and
coverslip. Stored at room temperature or 4C in a slide holder box. Looked under the
microscope.
Preparation of 4% PFA fixative without additive (25ml)
Added 1g of PFA to 15ml of autoclaved, stirring the water at 60C (waited for 15mins).
Added 5ul of 5M NaOH to get it dissolved (waited 15 mins). Added 2.5ml of 10X PBS.
Added autoclaved water to volume up to 25ml.
Preparation of 1% PFA fixative with additive (100ml)
1% PFA
2mM MgCl
5mM EGTA pH8.0
water)
0.2% NP-40
10X or 0.1M PBS
Autoclaved water

25ml of 4% stock
200ul from 1M stock
4.4ml from 0.1136M stock (solvent:
2ml from 10% stock (solvent: water)
10ml
Rest of the volume

Preparation of LacZ wash solution (100ml)
2mM MgCl2
0.01% sodium deoxycholate
0.02% NP-40
1XPBS

200ul from 1M stock (solvent: water)
100ul from 10% stock (solvent: water)
200ul from 10% stock (solvent: water)
rest of the volume
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Preparation of LacZ stain solution (or Xgal solution) (10ml)
Xgal stock
5mM Potassium ferricyanide
5mM Potassium ferrocyanide
LacZ wash solution

400ul of LacZ stock (25mg/ml)
16.5mg
21.1mg
9.6ml

Detailed information regarding regents used
Chemical
X-gal

Manufacturer
Cayman Chemical

PFA

Sigma-Aldrich

Neutral red

Sigma-Aldrich

NP40 or IGEPAL

Sigma-Aldrich

Sodium deoxycholate

ACROS

EGTA

VWR

Magnesium Chloride
Hexahydrate (MgCl2)
Potassium ferrocyanide
Potassium ferricyanide
EcoMount

EMD Chemicals

Microscope slides
(Superfrost Plus)
Size: 25x 75 x 1.0 mm
Cover Glass

Fisher Scientific

Sigma-Aldrich
Sigma-Aldrich
Biocare Medical

Fisher Scientific

Reference Code(s)
Item# 16495;
Batch# 0532100-17
Ref.# P6148;
Lot# MKCD5278
Ref.# 72210;
Lot: BCBP6989V
Ref.# I3021;
Lot:MKBC8185V
Ref.# 218590250
Lot#A0293327
Ref.#0732;
Lot: 18A3056246
Ref.# 5980
Ref.# P3289
Ref.# 244023
Ref.# EM897L;
Lot: 020618
Cat.# 12-550-15

Ref.# 12545F;
Lot:18838

Preparation of neutral red counterstain
500mg of neutral red was stirred in 100 ml of deionized water for overnight.
Later 1 drop of acetic acid was added.
IF staining followed by X-gal staining
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Fourteen um thickness of the brain samples were sectioned. Dried for 15-20
minutes in the air. Immersed in 1XPBS for 10 minutes. Fixed for 5 mins in 1%
PFA. Stored in 1XPBS at 4C until further use. Washed in LacZ wash solution for
15 minutes. Stained with X-gal solution (25mg/ml; pH 7.7) for 5 hours at 37C.
Wash with 1XPBS for 15-20 minutes under agitation. Antigen retrieved for 10
minutes at 90C in 1X Na-citrate buffer. Waited for the solution to cool down, and
avoided to take the slides out when the solution is hot. Rinsed in water. Incubated
for 1 hour in blocking buffer containing serum and 0.2% Tween-20, 1% BSA, 5%
donkey serum in 1XTBS at RT. Overnight incubated with blocking buffer with a
required ratio of primary antibodies in antibody dilution buffer, containing 0.2%
Tween-20 and 1% BSA. Incubated at RT with 1xTBS with only 0.2% Tween-20
for 5 minutes for 3 times. Incubated with the secondary antibody in antibody
dilution buffer for 2 hours at RT. Incubated at RT with 1xTBS with only 0.2% for
5 minutes for 3 times. Incubated at RT with DAPI in water for 5 minutes. Dried
and added Prolong antifade mountain agent before putting on the coverslips.
Primary Antibodies
Goat Polyclonal Anti-Lamin B
(1:200)
Secondary antibodies
4′,6-diamidino-2-phenylindole
(DAPI) (1:1000)

Santa Cruz
Biotechnology

Ref.# Sc-6217
Lot# J1311

Thermo Scientific

Ref.: 62248

Other reagents
Bovine serum albumin (heat-shock Fisher Bioreagents
treated)
Donkey serum
Lampire Biological
Laboratories
Molecular Biology grade water
Hyclone

CAS 9048-46-8
Cat.# 7332100
Lot: 13A29004
Cat.# SH30538-02
Lot: AAC200214
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Bisulfite-sequencing analysis
Total gDNA was extracted from tissues of mice, using DNeasy Blood & Tissue Kit
(Qiagen) manufacture’s instruction. Bisulfite conversion of the gDNA was performed by
using the EpiTect Plus DNA Bisulfite Kit (Qiagen). Nested PCR was set up using Ex-Taq
Polymerase

(Takara).

MethPrimer

(http://www.urogene.org/cgi-

bin/methprimer/methprimer.cgi) was used to design the bisulfite PCR primers shown in
table 2.5 (Li and Dahiya, 2002). The amplicons were gel-purified using the QIAquick Gel
Extraction Kit (Qiagen) followed by cloning into a TA vector (Stratagene). In a blue/white
colony screening, the white bacterial colonies were chosen for Sanger Sequencing. To get
the DNA methylation status, the sequence data were analyzed with the help of a
quantification tool for methylation analysis, QUMA (Kumaki et al., 2008)
(http://quma.cdb.riken.jp/top/quma_main_j.html). QUMA gave methylation plots, which
were next downloaded.
LacZ

WA1299, WA1300 (expected band at 526bp)

LacG

WA1301, WA1302 (expected band at 506bp)

Table 2.5 The primer pairs used for bisulfite sequencing of the transgenic lines.

Microscopy and image analysis
In general, Zeiss Axio Imager Upright microscope was used to take regular fluorescence
and bright-field images of different magnification of X20 or X40. Aperio VERSA Bright
field Fluorescence & FISH Digital Pathology Scanner (Leica, NJ) was used to scan the
whole-slide bright-field images of the stained sections at maximum 20X resolution. These
whole-slide images (extension .SCN) were navigated with the help of Aperio ImageScope
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(version 12.4.0.5043), a pathology slide viewing software, from Leica Biosystem, Leica,
NJ.
QuPath
The signals from bright-field or immuno-stained images were quantified with QuPath
(version 0.1.2) to quantify the percentage of positive cells with the required signals. The
file extension of the original, whole-slide images (.SCN) was not compatible with the
QuPath. Therefore, the images were converted to .TIF output (compression mode ‘LZW’)
with the help of image extract option in Aperio ImageScope (version 12.4.0.5043). The
interesting area(s) of the tissue sections were manually annotated to let QuPath perform
quantification based on the manual or pre-written scripts with the necessary instructions.

QuPath: quantification of signals
Two image types in the program QuPath were used for quantification: brightfield (H-DAB)
for X-gal stained tissues and fluorescence for immunofluorescence tissues. For the X-gal
stained tissues, a different script was created for each tissue based on its specific
characteristics. Each script was modified using a certain number of channels. Each channel
denoted a specific command to either denote a cell as either positive, negative, or border
based on the intensity of the hematoxylin or DAB. The mean, sum, and max intensity of
these two parameters were optimized over a range of several tissues to accurately detect an
X-gal positive cell from a negative. A percentage was then derived by taking the number
of positive cells divided by the number of negative cells plus positive cells and then
multiplied by 100. The cells detected as border were determined to be falsely detected cells
and were not included in this equation.
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QuPath Data Plot
The QuPath data were plotted using the ggplot2 package of the R software (version 3.6.2).
For any tissues with no detected X-gal positive cells, we plotted 1/(total number of cells)
since we could better see the data points (there would be too much clutter if we had plotted
them all as 0's). To make it clear that these data were referred to tissues with no detected
X-gal positive cells, we also created a binary column called Detected, which had a value
of "Yes" or "No". To further reduce the clutter, we used the position jitter function so that
there was less overlap between data points. We also used the log10 scale for the y-axis
since the range of y values (percentage of X-gal positive cells) is very small (0 to about 10
percentage). Thus, using the log10 scale improved the visual by "stretching out" the y-axis
and allowed us to better observe the entire range.

Statistics
Statistical analysis and mathematical calculations were performed using either Microsoft
excel. Sample means were compared with the help of two-tailed unpaired T-test used and
expressed in terms of the p-value. Analysis of replication consistency was tested with
Coefficient of variation (CV %) was used to analyze replicate consistency. Any CV values
with <100% were regarded to have data with less variation.

2.4 Results
2.4.1 Development and preliminary testing of LacZ based reporter transgenes for L1
promoter activity
To understand the in vivo promoter activity, the endogenous 5’-UTR promoter was fused
with either of the two reporter genes (Fig. 2.1a). The in vivo expression from these two
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transgenic constructs was analyzed in the transgenic mouse, with wild-type (C57BL/6)
genetic background, carrying the same transgene in a unique chromatic location.
Before generating transgenic mouse lines, we analyzed in vitro the transient expression
patterns of these two constructs in transfected mouse embryonic fibroblast cell line (3T3).
Here, we found a significant difference of expression in these two transgenic constructs, in
the presence of appropriate control with GFP plasmid (Fig. 2.1b). Transfection with a
plasmid (pWA370), enclosing 5’UTR-LacZ transgene, generated about 2.5 fold less X-gal
positive cells than that of its counterpart plasmid (pWA371), which carries 5’UTR-LacG
transgene. In vivo differences of their expression patterns in locus-dependent as well as
time-dependent manner were also determined in sections 4 & 5.
a. Sketch of our transgenes

b. 3T3 cells transfected with plasmids (pWA370 & pWA371)
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300 ng (GFP control)

10X 50 ng (GFP control)

10X

5’UTR-LacG (50 ng of pWA371)
10X 5’UTR-LacZ (50ng of pWA370) 10X
Figure 2.1. LacZ and LacG transgenes (a) sketch of the structure of LacZ and LacG
transgenes & (b) The transfection results in the 3T3 cells with the plasmids carrying the
transgenes.

2.4.2 Generation of transgenic mouse lines each carrying a single-copy 5’UTR-LacG
(or 5’UTR-LacZ) transgene at a random genomic locus
To obtain single-copy germline insertions for our transgene, the donor animal was bred
with H1t-SB100X positive transgenic animals (Grandi et al., 2015), expressing a
hyperactive Sleeping Beauty (SB) transposase specifically in pachytene spermatocytes
(Mates et al., 2009). Therefore, the excision of the transgene and their successive
mobilization happened in male germ cells, carrying both H1t-SB100X and the L1 transgene
(Fig. 2.2).
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Figure 2.2 Generation of single-copy mouse lines with the Sleeping Beauty DNA
transposon system

The progenies of this male with a wild-type female possess differential copy numbers of
transgenes. The transgenic mice with low-copy or single-copy number were identified,
using real-time PCR and droplet digital PCR, respectively. Next, the loci of these
transgenes were mapped (Fig. 2.3), and primers were designed for locus-specific PCR at
the junction of the transgene and genomic DNA. On some occasions, when the transgenes
moved further due to the presence of H1t-SB100X in the transgene positive animals, the
mobilization was detected with the help of the result of locus-specific PCR. In those cases
of a new position, the transgene was again mapped. A pedigree was maintained for these
single-copy animals (Fig. 2.4).
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Mapping protocol (adopted from Ivics et al., 1997)

A sample LMPCR-2 gel

Sequencing data of gel cut
Mouse Blat result

Figure 2.3 Steps to detect the single-copy mouse from the ones with high copy tandem
repeat, using techniques like (a) Real-Time PCR, (b) ddPCR, (c) gene mapping protocol,
(d) Ligation-mediated PCR, (e) sequencing of amplicons, & (d) BLAST.
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a. Primer design for LsPCR

b. LsPCR detecting the transgenic bands in three
different lines

LacG081

LsPCR for LacG141

C.

LacG221
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d.
Figure 2.4 Detection of transgenic loci for the sublines. (a) Design of primers for locusspecific PCR, using the BLAT results, (b) Sample of gels with expected bands from three
sublines, (c) a prototype of pedigree maintained for the single-copy mice, and (d) a list
specifying the details of the mapping result for the sublines.

2.4.3. X-gal staining to detect 5’UTR-LacG or 5’UTR-LacZ transgene
expression in mouse tissues in situ
In this part, X-gal staining for the cryosections was validated and optimized. As the
cryosections were X-gal stained and followed by counterstain with neutral red. We
observed the X-gal signals being colocalized with neutral red (Fig. 2.5.a) under light
microscopy. Upon immunostaining of the X-gal stained sections, we observed the blue
stains surrounded by lamin B signals (Fig. 2.5.b). This added to the 2nd line of verification
of our X-gal stains. Later, we optimized pH of the X-gal solution to an optimum point
which is suitable to eliminate the signals from endogenous beta gal if present in any tissue.
We use Z/EG transgenic mouse as a control. We also found that at pH 7.7, ZE/G kidney
maintained a substantially intense X-gal signal (Fig. 2.6).
The optimum level of fixation of tissues in fixative is necessary for an ideal X-gal staining
at determined pH. Additionally, a perfect fixation condition would provide us with a better
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morphology of the tissues in the shortest period, retain the maximum β-gal from a timedependent degradation, and prevent over-fixation of tissue to guarantee maximum stain. In
neonatal time point, we observed that drop-fixation condition with 2% PFA with additives
for 4 hours turned out to be the best condition with the shortest period and with using the
lowest concentration of fixative possible (Fig. 2.7). On the other hand, at an adult time
point, the longer time and higher concentration of fixative – i.e. 6 hours into an additivemixed 4% PFA solution devoid of glutaraldehyde - were essential to stain the tissue
samples (Fig. 2.8). Notably, in both of these time points, control Z/EG tissues were used.
Finally, desired staining patterns, which matched with their corresponding genotypes, were
attained for all five genotypes used in this study (Fig. 2.9). Next, the whole slide scanned
images of the tissue sections obtained from different lines in various context, we quantified
the X-gal signals using the QuPath software. It uses a machine learning approach to bioanalyze the whole slide images. This allows a user to teach QuPath how to distinguish
individual cells by separating stains and also determining the intensity peaks for either
neutral red, X-gal, or both (X-gal positive cells) within a marked annotation (Fig. 2.10). It
was possible to make the detections fully automated using scripts.
a. Validation with neutral red

N573 (Brain), 20X
b. Validation with immunostaining with Lamin B antibody

40X
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N573 (Brain); X-gal (Brightfield x20)

N573 (Brain); Lamin B (FITC, X20)

N573 (Brain); Lamin B (FITC) merged
N573 (Brain); DAPI merged with X-gal
with X-gal (BF), X20
(BF) , X20
Figure 2.5: Validation of X-gal signals. (a) Validation with neutral red co-staining. (b)
Validation with X-gal staining followed by immunostaining with Lamin B antibody.
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Figure 2.6 A pH gradient (7.5, 7.7 and 8.5) of X-gal solutions was used to stain adult
kidney sections from the non-transgenic mouse as well as Z/EG mouse.

Neonatal kidney of Z/EG mouse

6 hours in 4% PFA

6 hours in 2% PFA
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4 hours in 4% PFA
4 hours in 2% PFA
Figure 2.7: In search of a suitable tissue fixation condition, different combinations of
duration and conc. of fixatives were used in the neonatal kidney of Z/EG mouse.

Adult kidney of Z/EG mouse

6hr (4%PFA + additives) + glutaraldehyde

6hr (4%PFA + additives) -glutaraldehyde
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4hr (4%PFA + additives) + glutaraldehyde

4hr (4%PFA + additives)- glutaraldehyde

Figure 2.8: In search of a suitable tissue fixation condition, different combinations of
duration and conc. of fixatives were used in the adult kidney of Z/EG mouse.

ZEG positive (ZEG070), Brain(Thalamus) Transgene negative (N609), Brain
(Thalamus)

63

LacG positive (N573), Brain ( Thalamus) LacZ positive (N483), Brain (Thalamus)
Figure 2.9: Desired staining patterns matched with their corresponding four genotypes
used in this chapter.

Figure: 2.10 Detection of X-gal positive cells using QuPath. Here, Original column,
corresponding to each organ shows original stained tissues. When these regions were fed
in QuPath for quantification, the detections were shown to be annotated accurately with
red borders for counterstains (neutral red) and blue borders for X-gal stains.
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2.4.4 Random lines with 5’UTR-LacZ had low expression at all time
points

Figure 2.11 In vivo promoter activity of 5’UTR fused with WT-LacZ sequence, being
placed in three random genomic loci at three different time points.

Neonatal time point has detectable signals only in brains (of 2 out of 10 animal for all three
lines) and kidneys (of 3 out of 10 animals for all three lines). For kidney, all 3 of 10 animals
belonged to one particular line, LacZ0163. For the brain, 2 of the 3 detectable values were
from another particular line, LacZ0163. However, in other neonatal organs, there are no
detectable signals. The highest level of detectable expression for the neonatal brain was
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0.003%, and for kidney, it is 0.06%. On the other hand, at an adult time point (aging 2
months), several organs showed to have detectable values, namely lung, kidney, spleen and
testis (Fig. 2.11).
Finally, most of the old animal (aging 12 – 18 months) brains had a detectable range of
values of around (Fig. 2.11). Among 10 animals, 2 were undetected with a detectable range
of 0.001- 0.04%. Kidney and testes consistently have the highest level of expression at the
old-time point. In the case of the kidney, 3 of the 4 highest values are coming from a
particular line, LacZ0161. In the case of the testis, 2 of the top 3 highest values are coming
from a particular line, LacZ0160. In spleen, lung, liver, and heart, however, showed
minimum expression.
Among the three time points, the highest value of the percentage of the X-gal positive cells
is still below 1%. Heart, liver, & lung showed the most number of undetectable signals,
say 19 out of 21, or ~90 % of animals showed no signals in the heart. Twenty-two out of
23 animals i.e. ~95 % of animals showed no signals in the liver, whereas out 20 of 22
animals, or in other words, ~90 % of animals showed no signals in lungs. Most signals are
undetected in neonatal and adult (Fig. 2.12); however, the most number of detectable
signals were found at aged animals. In all three lines, during the old-time point, kidneys
and testes showed a consistent expression pattern. Moreover, the kidney also showed the
highest number of expression in old animals. Among three lines, LacG0160 showed
comparatively lower expression in kidney than the other two lines, whereas LacZ0161
showed lower testis expression than the other two.
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(a) Neonatal

(b) Adult

G0510 (Brain)

G0453 (Brain)

G0478 (Heart)

G0468 (Heart)

G0483 (Lung)

G0453 (Lung)

G0488 (Liver)

G0468 (Liver)
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G0508 (Spleen)

G0452 (Spleen)

G0488 (Kidney)

G0468 (Kidney)

G0510 (Testis)

G0452 (Testis)
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(c) Aged

G0458 (Brain)

G0435 (Heart)

G0435 (Lung)

G0436 (Liver)

G0436 (Spleen)

G0457 (Kidney)

G0437 (Testis)
Figure 2.12. LacZ tissue sections with low/no staining at 20X
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Figure 2.13 showed few of the histological locations on the tissues, where X-gal stains
were found to be present relatively more in number in some of the organs across three
different time points. Interestingly, some of these animals were litter-mates of the animals
showed in the above panel. In testis, X-gal positive cells lied at the border of the
seminiferous tubules. In brain and kidney sections belonged to neonatal and old, X-gal
positive cells were found to present in the cluster.
Neonatal

G0481(Brain)

Adult

G0508 (Kidney)

G0451 (Spleen)

Aged

G0458 (Brain)
G0401 (Kidney)
G0436 (Testis)
Figure 2.13 Substantially (X-gal) stained LacZ tissue sections at 20X (labelled the
positive cells with yellow arrow)
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2.4.5. Random lines with 5’UTR-LacG had variable expression in all
time points
Contents:
2.4.5.1 Expression level during a neonatal time point
2.4.5.2 Expression level during an adult time point
2.4.5.3 Expression level during a geriatric time point
2.4.5.4 Kidney showed as the most common preferential organ with the highest number
of promoter activity among four lines across different developmental time points
2.4.5.5 Heart showed the highest signals but they are uncommon
2.4.5.6 Drastic change of expression was noticed upon moving of transgene to a new
locus

2.3.5.1 Expression level during a neonatal time point
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Figure 2.14 The promoter activities (in percentage of positive cells) in different neonatal
organs of all sublines belonged to LacG line. (a) Line-wise (b) organ-wise distributions.

The expression in brain varied across the lines with a least detectable value at 0.003% to
highest being at 0.6%. LacG071 is the highest expression in the brain, where the individual
values varied highly. Heart values were highest among all the tissues. LacG071 showed
the highest activity among the heart values in an average. However, in the heart, many
positive signals were not localized in the nuclei. This will be separately reported in the next
section below. No detectable values were found in spleen and testis. Expression values
fluctuated a lot in most of the organs. LacG071 and LacG061 showed most expressions of
high values. Livers & lungs had detectable expressions. In testes, no detectable values were
observed at the neonatal stage (Fig. 2.14).
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2.4.5.2 Expression level during adult time point

Figure 2.15 The promoter activities (in percentage of positive cells) in adult (56 days
old) organs of all sublines belonged to LacG line. (a) Line-wise (b) organ-wise
distributions.

LacG071 has the highest numbers of X-gal positive cells (i.e. ~1-2%) in the brain with
less standard deviation (Fig. 2.15). Heart again has leading values in all lines, and the
levels of these values are comparable to brain and kidney. Liver, lungs and spleen had
a low profile, but LacG082 had no signal in the liver. Unlike neonatal time points,
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spleens and testes have detectable values in adult time points. Testes have most
detectable values in LacG071.

2.4.5.3 Expression level during geriatric time point

Figure 2.16 The promoter activities (in percentage of positive cells) in old animals’
organs of all sublines belonged to LacG line. (a) Line-wise (b) organ-wise distributions.

At this time point (Fig. 2.16), some of the new lines included which were not
represented earlier in two-time points. LacG066 had the highest level of expression in
the brain (4%), disregarding heart with >10% of positive cells. A comparative level of
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expression was observed in LacG071 line, however, with at least 10-fold difference
among individual mice. Kidney has the highest level of expression in LacG066 among
all samples and all lines. Values from kidneys were comparable to the values from the
heart in terms of magnitude. Liver and lung showed low profile. Testes values increased
quite significantly as compared to the adult time point.

2.4.5.4 Kidney showed as the most common preferential organ with highest number
of promoter activity among four lines across different developmental time points
Neonatal
Adult
Old-aged
Kidney
Kidney
Testis
(0.121%)
(0.174%)
(0.456%)
LacG061
Kidney
Brain
Testis
(0.589%)
(0.577%)
(1.139%)
LacG071
Lung
Brain
Kidney
(0.032%)
(0.013%)
(0.186%)
LacG082
Kidney
Kidney
Kidney
(0.224%)
(0.114%)
(0.289%)
LacG221
Table 2.6: The organ had the highest expression in different lines

Above table (Table 2.6) summarizes the organs that were found to have the highest
mean of the expressions in three-time points across four random lines. Following
histograms (Fig. 2.17) are showing different mathematical values supporting the table
above. In histograms, the y-axis is the percentage (%) of positive cells and x-axis is
different organs. Here we see, out of 4 unique organs in this table (brain, lung, kidney
and testes) across 4 different lines, the kidney is seemingly the most preferential organ
for high promoter activity among all the time points. Spleen seemed to be the lowest
expressive organ. Heart values were also excluded from this comparison. Substantial
standard deviation was observed. LacG082 line showed the lowest level of expression,
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where expression was silent in almost all tissue. LacG071 line showed the highest level
of expression in brain, kidney and testes.

Figure 2.17 Histograms showing average promoter activity (%) in different main organs
across four different lines.

2.4.5.5 Heart showed the highest signals but they are uncommon
In all time points of LacG lines, many granulated, non-nuclear localized X-gal positive
signals have been observed, which, in turn, increased the positive signals in the heart.
On the contrary, the non-transgenic animals possessed no signals at all (Fig. 2.18).
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Heart signals in LacG lines
LacG positive
LacG negative

LacG071/ N574 (LacG+), Heart 10X

LacG071/ N807 (LacG-), Heart 10X

LacG061/ N617(LacG+), Heart 10X

LacG061/ N710 (LacG-), Heart 10X

LacG082/ N583(LacG+), Heart 10X

LacG082/ N626 (LacG-), Heart 10X
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LacG221/N601(LacG-), Heart 10X
LacG221/ N603(LacG+), Heart 10X
Figure 2.18 Uncommon x-gal signals in heart of LacG positive animals vs LacG
negative animals

2.4.5.6 Drastic change of expression was noticed upon moving of transgene to a new
locus
During the transition from 2nd generation to the 3rd generation, transgene moved from a
mapped locus point of LacG066 (Chr. 15) to a new location of LacG221 (Chr. 14). More
specifically, the only survived animal belonged to LacG066, N066, was a transgenic parent
of the founder of LacG221 line. At the old stage, a drastic change of expression was noticed
in the brain and kidneys of N066 in compared to the same of the progenies of LacG221.
The former showed the highest load of positive signals ever noticed in any animals of LacG
lines. On the other hand, a minimum expression was observed in the tissues of animals of
comparable age belonged to LacG221 line (that includes N395 and N425 as aged members)
(Fig. 2.19).
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Kidney
30.00

Brain: Cerebellum
25.00

22.17

20.00

15.00

10.00

0.34

0.24

5.00

N395

N425

-5.00

0.00
N066
LacG066

LacG221

N066, Kidney X10

LacG221/N395, Kidney X10

4.11
N066

0.07

0.01

N395

N425

LacG066

LacG221

N066, Cerebellum X10

LacG221/N395, Cerebellum X10

LacG221/N425, Cerebellum X10
LacG221/N425, Kidney X10
Figure 2.19: The contrast between the x-gal signals in kidneys and cerebellums of
LacG066 and LacG221 animals.
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2.4.6. LacG071: The line with high transgenic expression in most of the
tissues at all time points
Contents:
2.3.6.1 The promoter activities in different organs of LacG071 varied across three
developmental time points
2.3.6.2 Brain regions of LacG071 have heterogeneous activity pattern
2.3.6.3 Thalamus is the most common preferential region for promoter activity
across different random lines

2.3.6.1 The promoter activities in different organs of LacG071 varied across three
developmental time points

Figure 2.20 The promoter activities in different organs of LacG071 varied across three
developmental time points
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Brain, heart and kidney showed high expression (Fig. 2.20). With less standard deviation
(coefficient of variation (CV) %= 62.82, around 1% of the brain cells showed positive
signals in adults, unlike other two time points. While, the liver, lungs and spleen showed a
low promoter activity. No detectable value was found in the spleen during neonatal time
point; however, in some adult individuals, the average value is 1 positive cell per 10,000
cells. Interestingly, no signal was detected in testes at a neonatal time point, but signal level
consistently kept rising in subsequent ages, adults and aged. The above result was
supported by the following images of different developmental time points (Fig. 2.21).
Neonatal

Adult

N573 (Brain)

N522 (Brain)

N573 (Heart)

N524 (Heart)

N573 (Lung)

N524 (Lung)
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N805 (Liver)

N524 (Liver)

N573 (Spleen)

N795 (Spleen)

N574 (Kidney)

N795 (Kidney)

N573 (Testis)

N524 (Testis)
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Aged

N441 (Brain)

N444 (Heart)

N486 (Lung)

N450 (Liver)

N441 (Spleen)

N450 (Kidney)

N444 (Testis)
Figure 2.21 Sample images (at 20X) of all organs of LacG071 at three different time
points.
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2.4.6.2 Brain regions of LacG071 have heterogeneous activity pattern

Figure 2.22 L1 promoter activity (%) in different brain regions of mice belonged to
LacG071 line

At Neonatal of LacG071
At the neonatal time point of LacG071, thalamus showed the highest values in at least two
animals out of four in total. The average values from all four animals were 0.44%, which
is the highest among all other averages from other regions for this time point.

At the adult time point of LacG071
In adult animals of LacG071, out of four animals, three animals showed very high signals
in the hippocampus, showing a definite expression in the dentate gyrus (Fig. 2.23). One
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specific animal, N522, showed a high level of X-gal signals in the cortex (16.56 %) and
hippocampus (14.07 %) of all adult stage animals. Except the mentioned, outlying values
of N522, first and second most expressive regions were thalamus and Hypothalamus
respectively. However, wide variability was observed in thalamus values among the
animals (CV% = 118.46).

At the old time point of LacG071
Average values from thalamus fell back sharply during older age from a peak state of adult
time point. However, this region still leads in the average transgenic expression among the
old animals and ties with the cortex value. A drastic change of falling of hippocampus
value is a worth taking attention.
Very interestingly, adult time points showed consistently the highest average levels of
positive signals in all brain regions of LacG071. Cerebellum showed minimum expression
in all-time points of LacG071 line. Overall, with the change of developmental time point,
sharp fall and rise of the expression were observed in hippocampus, cortex, hindbrain,
hypothalamus, and thalamus values (also in Fig. 2.27). Thalamus was the most common
region for the promoter activity in all-time points of the LacG071 line (Fig. 2.23 and Fig.
2.27). A specific expression pattern along the dentate gyrus of the hippocampus in all-time
points of the LacG071 line was observed (Fig. 2.23).
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Transgenic expression in the
dentate gyrus

Transgenic expression in the
thalamus

N574 (Brain, Hippocampus)

N804 (Brain, Thalamus)

N795 (Brain, Hippocampus)

N524 (Brain, Thalamus)

Neonatal

Adult

Aged

N446 (Brain, Hippocampus)
N446 (Brain, Thalamus)
Figure 2.23: Sample images (at 10X) of all brain regions (hippocampus & thalamus) of
LacG071 at three different time points.
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2.4.6.3 Thalamus is the most common preferential region for promoter activity
across different random lines
2.4.6.3.1 Brain regions of LacG061 line

Figure 2.24: L1 promoter activity (%) in different brain regions of mice belonged to
LacG061 line

Overall, the brain regions of all animals across different time point showed very low
expression (Fig. 2.24). Hindbrain tops the list. In adults, thalamus and hypothalamus
showed increased values in a single animal out of two. Again at the old-time point,
hindbrain and cerebellum showed consistently increased values in both animals.
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2.4.6.3.2 Brain regions of LacG221 line

Figure 2.25: L1 promoter activity (%) in different brain regions of mice belonged to
LacG221 line

In both neonates and adults, hindbrain showed detectable values in all animals. And
among adults, one animal showed high detectable expression in the hypothalamus.
Whereas, thalamus topped in one of the old animals as the leading value, whereas in
another animal in went undetectable (Fig. 2.25).
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2.4.6.3.3 Brain regions of LacG082 line

Figure 2.26 L1 promoter activity (%) in different brain regions of mice belonged to
LacG082 line

It consistently maintained a low level of expression in all animal regardless of the time
point. However, hindbrain leads in Neonatal, the hypothalamus in adults, and thalamus
expression was prominent in the old animal (Fig. 2.26).

2.4.6.3.4 In search of a common region(s) with the most expression:
Among the four lines, LacG071, LacG061, LacG082 & LacG221, it was pertinent to know
which brain area had the most expression and also whether any particular region had
consistently most transgenic expression. The table (Table 2.7) below summarized the
histograms (Fig. 2.27), showing average promoter activity (%) among three time points
across 4 different random lines.
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Sublines
LacG071

Neonatal
Adult
Old
Thalamus
Hippocampus
Thalamus & Cortex
(0.44%)
(5.03%)
(0.35%)
Hind brain
Thalamus
Cerebellum
LacG061
(0.02%)
(0.15%)
(0.17%)
Hind brain
Hypothalamus
Thalamus
LacG221
(0.09%)
(0.23%)
(0.13%)
Hind brain &
Hypothalamus
Thalamus
LacG082
Hypothalamus
(0.02%)
(0.06%)
(0.02%)
Table 2.7 The mouse brain regions with the highest promoter activity in four different
lines at three developmental time points

Here we see, out of 5 unique regions (hindbrain, hypothalamus, thalamus, cortex, and
cerebellum) of 4 different lines, the thalamus is seemingly the most common (as it
appeared in 5 cases out of 14), a preferential region of promoter activity of all the time
points, whereas hypothalamus and hindbrain take jointly 2nd position with 3
appearances, and cerebellum, hippocampus and cortex for 1 time each only. N522
animal particularly showed a high number of positive cells in most of the regions of its
brain. Cerebellum showed consistently the lowest level of expression in all-time points,
except old time point in LacG061. Hippocampus, though appeared one time but carries
the highest value (5.03%) among all the regions been compared. Therefore, it might be
the less preferential region of promoter activity. Here, a high standard deviation among
the expression values was observed. Figure 2.28 is showing the data distribution of the
animals of LacG071 sublines in three time points.
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Figure 2.27: Histograms showing average promoter activity (%) (in the y-axis) in
different brain regions of mice belonged to four different lines at three different time
points
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Note: Alternative graphs to observe each data point belonged to LacG071:

Figure 2.28 The variation of the values of different brain regions of LacG071 line.

2.4.7 Promoter regions of LacZ and LacG transgenes are
hypermethylated

Two different tissue samples (brain and kidney) of one animal from each line were
extracted for the DNA. The DNA was bisulfite converted, and the methylation of a part of
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promoter region DNA was analyzed. The brain and kidney samples of LacZ line showed
respectively 94.3% and 93.7% of DNA methylation. While LacG line showed
comparatively higher methylation status of 97.3% and 98.2% in brain and kidney,
respectively (Fig. 2.29a). Figure 2.29b shows that even after having so much methylation
at the promoter site, the tissues of the sample animal showed expression in LacG line, not
the LacZ line.

a.
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b.

Figure 2.29 The bisulfite sequencing data for DNA methylation analysis. (a) Methylation
levels of part of the promoter of both transgenes & (b) transgene expression in the tissues.

2.5 Discussion
Vast sequence homology of endogenous LINE-1s barred us from using an appropriate
technique to harness the locus-specific information of L1 promoter activity. Here, we
utilized a transgenic approach to know the locus-dependent expression pattern of LINE-1
promoter activity.
Unlike A and F subfamilies, TF is the youngest subfamily of mouse LINE-1. With an
abundant expression in the mouse genome, it carries 4000-500 full-length members. Due
to having a large number of active members, it is an expanding sub-family of mouse LINE1. L1spa is a name of a full-length LINE-1 insertion caused by this TF subfamily, and this
L1spa cause disease in mouse (Kingsmore et al., 1994; Takahara et al., 1996; Naas et al.,
1998). Therefore, we wanted to characterize the promoter activity of this L1spa.
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Therefore, we fused the 5’-UTR promoter from this L1spa sequence and attached to
LacZ/G reporter to make our transgene) (Fig. 2.1a). With the help of pronuclear
microinjection procedure, we were able to integrate our transgene into random
chromosomal sites.

Later, with the help of histochemical detection of the reporter

expression, we quantified the promoter activity of the LINE-1 promoter activity. In most
of the sublines and organs, we found a silencing effect of the transgene.
There are several general reasons for gene silencing. Due to the influence of the sites of
the chromosome, the stably integrated transgene are often poorly expressed (Bestor et al.,
2000, Fiering et al, 2000). Several other factors are attributed to the variation of transgene
expression, include the differences in copy number and location of the chromosome, and
fidelity of the transgene construct itself (Matzke & Matzke, 1998; Kooter et al., 1999) as
well as an epigenetic factor, like position-effect variegation (PEV) and DNA methylation.
It has already been shown that LINE-1 transcriptions have been influenced by the upstream
gene sequences (Lavie et al. 2004). Additionally, promoter methylation is one of the
strongest candidates for gene silencing. In general, DNA methylation can also be inherited
in subsequent generations (Balow, 1995; Schumacher et al., 2000; Kearns et al., 2000).
Other candidates for gene silencing could be histone modifications or other epigenetic
factors (Kearns et al., 2000; Mehta et al., 2009).
In general, the position effects can be observed in two types in vitro, stable and silencing.
In the stable category, the transgene expression is obtained pervasively in most of the cells
in a similar manner. This expression will be essentially different from the similar transgene
or endogenous gene, being embedded in a different site. On the contrary, the silencing
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category involves with the heterocellular expression, where except being expressed in few
cells, the transgene is silent normally silent (Pikaart et al., 1998; Walters et al., 1996).
Nevertheless, a suitable detection technique to report promoter activity was needed. For
the detection techniques, it was vital to opt for a sensitive technique, which should be
equally sensitive and quantitative enough for in situ signal detection as well as having a
robust screening efficiency with less experimental variations. Thereby, we chose LacZ
reporter assay or X-gal staining.
Originally, the LacZ gene encodes β-galactosidase in Escherichia coli. This enzyme can
also hydrolyze different synthetic (chromogenic and fluorogenic) chemical substrates.
Thus, X-Gal, a colorless chemical, is cleaved by this enzyme to produce a blue-colored
compound, 5-bromo-4-chloro-indole, which is easy to detect in an in situ screening
procedure. Therefore, LacZ fusion with a promoter of interest could be used to characterize
the activity of a promoter in cell lines or can be used to generate a transgenic mouse line.
Over 30 years ago, the first transgenic LacZ mice were generated (Kothary et al., 1988;
Kothary et al., 1989). Since then this versatile reporter gene has been used to create several
mouse models to characterize the expression of genes and also to trace the cells lineage
during development. This reporter assay provides an indirect measurement of promoter
activity, yet it is a highly straightforward, time-saving, and reproducible, requiring no
expensive reagents and equipment.
However, bacterial-origin LacZ gene shows the CpG content of 9.24% (Chevalier-Mariette
et al., 2003). The methylation of 5'-CpG-3' dinucleotides within genes mostly creates
potential targets for the protein complexes that bind onto methylated DNA sequences and
also to histone deacetylases. These bindings could lead to transcriptional repression by
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modifying the chromatin landscape. There is evidence as methylation of non-promoter
sequences could result in transcriptional silencing of reporter genes (Kass et al., 1997;
Hsieh et al., 1994).
Hence, to avoid the silencing of the promoter activity due to the methylation of the gene
body containing the reporter cassette, a CpGless version of the CpG-rich LacZ gene (i.e.,
LacG) was engineered by eliminating the CpG dinucleotides. This class of CpGless-LacG
construct was previously designed by Henry et al. in 1999 (Henry et al., 1999), and the in
vivo activity in late-stage of developing mouse was not realized in wide-range of mouse
organs until 2003 by the same group (Chevalier-Mariette et al., 2003). There, widespread
repression of CpG-rich LacZ transgene was observed even at single copy level in all
somatic tissues, whereas substantial expression was acquired with the CpG-less LacZ
transgene in contrary (Chevalier-Mariette et al., 2003).
Since we did not have any data how the transgene should function in vivo, therefore
initially, we tried to understand the difference of X-gal staining of these two transgenic
constructs with the help of in vitro transfected cells, embryonic fibroblast cell (3T3 cell
line). We found that 5’UTR-LacZ transgene showed less expression than the 5’UTR-LacG
(Fig. 2.1b). However, we created two mouse lines to understand the difference between
their in vivo regulations.
Importantly, when the transgenes (5-UTR-LacZ and 5’UTR-LacG) were constructed, we
also included an important design in which both transgenes were flanked by two inverted
terminal repeats (ITRs) from the Sleeping Beauty (SB) DNA transposon. The utility of this
design will be described in the text below. These plasmids were injected into the pronuclei
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of fertilized oocytes by Cyagen Biosciences. Subsequently, founder mice carrying multicopies of either transgene in a tandem array within a single locus were generated (Fig. 2.2).
As explained below, the embedding of SB-ITRs in the transgene would allow us to derive
an unlimited number of transgenic mouse lines carrying a single copy of the transgene. The
rationale for using single-copy instead of multi-copy transgenic lines to profile L1
promoter activity is two-fold. First, endogenous L1s, by definition, are interspersed and
present in the mouse genome as discrete, individual copies, not in the form of tandem
arrays. Second, it is known that tandem arrayed sequences subject to additional
mechanisms of transcriptional regulation. This phenomenon has been previously
documented for transgenes and referred to as “repeat-induced gene silencing (RIGS)”.
Silencing of transgenes in animals with a high copy number is a regular feature of
pronuclear microinjection method of animal transgenesis. Expression of large tandem
arrays of repeated sequences may suppress the efficient transcription of transgenes (Simon
& Knowles, 1993; Dorer & Henikoff, 1994). Indeed, our lab has observed RIGS for a
tandem repeated L1 transgene carrying a heterologous CAG promoter (Rosser & An,
2010). Therefore, it was essential to reduce the number of copy number of transgenes. At
the same time, we wanted to mobilize the single-copy transgenic cassette to random loci in
order to create unique locus-specific mouse lines. These two purposes were resolved with
the help of the Sleeping Beauty (SB) DNA transposon system.

Sleeping Beauty (SB) transposon system is a novel genetic tool that was developed around
two decades ago (Ivics et al., 1997). It consists of two components: first, an excisable DNA
sequence flanked by two ITRs, which are the essential sequence for the recognition and
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mobilization by the SB transposase, the second component. Thus with the help of the latter,
the former component is eventually excised and reinserted into other locations of the
genome (Ivics et al., 1997).

To obtain single-copy germline insertions for our transgene, the donor animal was bred
with H1t-SB100X positive transgenic animals (Grandi et al, 2015), expressing a
hyperactive SB transposase specifically in pachytene spermatocytes (Mates et al., 2009)
Therefore, the excision of the transgene and their successive mobilization happened in male
germ cells, carrying both H1t-SB100X and the L1 transgene).

The progenies of this male with a wild-type female possess differential copy numbers of
transgenes. The transgenic mice with low-copy or single-copy number were identified,
using real-time PCR and droplet digital PCR, respectively. Next, the loci of these
transgenes were mapped (Fig. 2.3), and primers were designed for locus-specific PCR. On
some occasions, when the transgenes moved further due to the presence of H1t-SB100X
in the transgene positive animals, the mobilization was detected with the help of the result
of locus-specific PCR. In those cases of a new position, the transgene was again mapped
(Fig. 2.4).
X-gal staining is a fast and convenient histochemical technique to detect the expression of
the LacZ reporter gene. The bacteria (Escherichia coli) derived LacZ gene encodes the βgalactosidase (β-gal) enzyme. β-gal can hydrolyze different synthetic substrates. For
example, X-gal (5-bromo-4-chloro-3-indolyl-beta- D-galactopyranoside), a synthetic
colorless b-gal substrate. It can be enzymatically cleaved by β-gal into galactose and 5-
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bromo-4-chloro-3-hydroxyindole. The latter compound gets further oxidized into 5, 5’dibromo-4, 4’-dichloro-indigo, which is blue. In sum, cells expressing the LacZ reporter
can be visualized with X-gal staining.
In this study, the wild-type LacZ and its CpG-less derivative LacG were placed under the
control of endogenous promoters for LINE-1, i.e. 5’UTR. The expression from them was
marked by a dark blue stain, which was detected and quantified at the single-cell level,
providing a robust visual readout of LINE-1 promoter activity in the main organs of
developing mouse.
It is already known that many mammalian tissues synthesize endogenous β-gal (GLB1
gene product). This is a physiologically significant lysosomal enzyme that helps in the
enzymatic degradation of glycolipids in some of the tissues. Kidney, intestine, and
epididymis are some of these tissues, which are a particularly rich source of endogenous
β-gals in mammals, although their presence may vary species to species (Conchie et al.,
1958; Pearson et al., 1963).
Lysosomes have an acidic environment within it, and therefore, consistent with its
localization lysosomal β–gal exhibits maximal activity within the range of pH 4.0 and 4.5
but significantly lower activity at pH 6.0 or higher (Zhang et al., 1994). Importantly,
proliferating cells have undetectable β-gal activity in situ with an X-gal staining buffer at
pH 6.0 (Kurz et al., 2000). Yet, in senescent cells, the GLB1 gene product was reported to
be the origin of senescence-associated β-gal activity (SA β-gal) (Lee et al., 2006).
Therefore, if X-gal staining is found at or higher pH 6.0, it should be either originated from
senescent cells with increased lysosomal β-gal activity or transgenic b-gal. Therefore, it is
a technical challenge for X-gal staining to distinguish between these two types of β-gals.
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Different modifications to the X-gal technique were previously adopted by various groups
to increase the specificity of exogenous LacZ detection in respective experimental setups.
These included exposing LacZ tissues to X-gal at a point below 37°C (Weber- Benarous et
al, 1993; Sanes et al, 1986), or utilizing alternative chromogenic substrates as well as the
fluorescent substrates of X-gal compound (Weis et al, 1991; Liu et al, 1996, Aguzzi and
Theuring, 1994; Pearson et al., 1963; Brunet et al., 1998; Kishigami et al., 2006, Zhang et
al., 1991). However, none of these methodologies is widely used. Here, we utilized two
different strategies to enhance the specificity of X-gal detection.
First, to enhance the specificity, the reporter gene, carrying a nuclear localization signal
that results in producing nuclear-localized β-gal rather than cytosolic forms, can also be
utilized to distinguish between endogenous and exogenous signals (Bonnerot et al., 1987).
Therefore, in our transgenic construct, we embedded a sequence of nuclear localization
signal as part of the coding sequence. When the cryosections of the organs were treated
with X-gal staining solution, we observed the X-gal signals being colocalized with neutral
red (Fig. 2.5.a), a planar phenazine dye, which found to interact with DNA (Wang et al.,
2003; Huang et al., 2001) in the nucleus. In addition to that, we validated our X-gal signals
with immunostaining. Here, we used fluorescently labelled antibodies against lamin B, a
protein that is anchored to the inner nuclear membrane. The antibody fluorescently marks
the circumference of nuclei. Indeed, the X-gal stains, blue under the visible light source,
were found to be surrounded by lamin B signals (Fig. 2.5.b). Therefore, these results
confirmed that the observed X-gal signals were solely derived from the transgene.
Second, we used an optimized pH of the X-gal solution to rule the chances of detection of
the X-gal signals out of endogenous β-gal, which, as mentioned earlier, were generally
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active in acidic pH and inactive in high pH. To do so, we had to select an exact pH point
from a relatively high pH gradient (7.5, 7.7 and 8.5). We observed that (Fig. 2.6) at pH 7.7,
non-specific signals are eliminated in non-transgenic, adult mouse kidney. This condition
also maintained substantially intense X-gal signals in the positive control Z/EG mouse.
Z/EG (LacZ/EGFP) mouse line is a double-reporter mouse line. The reporters are driven
by a strong CMV early enhancer/chicken beta-actin (CAG) promoter. A LacZ gene, one
of the reporter gene, is flanked by two loxP sequences and also followed by enhanced green
fluorescent protein (EGFP) sequence (Fig. 2.6). Cre-mediated recombination removes the
LacZ gene, and thus activates expression of the second reporter. Nonetheless, the CAG
promoter maintains the expression of LacZ throughout its all developmental stages by
default (Novak et al., 2000). In this control mouse line, the LacZ is not embedding a nuclear
localization signal; as a result, the X-gal signals mostly come from the cytoplasm, unlike
the reporter mouse lines generated for this study. Moreover, this signal mostly found to
diffuse to form a smear over the surrounding cells.
Later on, we optimized drop fixation condition also depending upon the mouse
developmental time points to get a substantial signal intensity and a better morphology
(Fig. 2.7 & Fig. 2.8). Multiple tissue sections from the both of major transgene lines were
screened for quantification of the X-gal signals.
In the LacZ line, a very small percentage of neonatal animals showed positive signals in
no more organs than the brains (20%) and kidneys (30%) only (Fig. 2.11). The highest
detectable signal obtained in the brain was this clearly shows that at this time point, the
expression of LacZ transgene was silent. Therefore, not much information regarding other
organs can be harnessed with the help of this transgene construct for this time point.
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However, interestingly, all animals with the detectable expression values in the kidney
belonged to one particular locus. Similarly, 2 out of 3 detectable brain values are also
confined to another unique locus. Although the sample numbers are not large enough, still
it might be suggesting that with taking age as a factor, expression from this transgene is
dependent on the locus point where transgene is placed in the genome. It is also true that
the detectable values are very rare in both brains and kidneys. The highest detectable value
in the neonatal kidney was recorded as 6 positive cells in 10,000 cells. Upon transitioning
to adult time point, we observed more number of organs showed detectable values outside
the brain and kidney. At the geriatric time point (12 to 18 months old mice), X-gal stained
cells were mostly found as shown in the scattered plot. This is a situation opposite to the
neonatal time point. Here, rather, 20% of the brains showed detectable signals, although
the detectable signals were of low range i.e. 0.001 - 0.04%. At this time point, besides the
brain, kidney and testes showed a locus-dependent expression pattern with relatively higher
detection values compared to other organs, like spleen, lung, liver and heart. The kidneys
of the old animals showed more number of expression particularly. This might be an agedependent, tissue-specific change of DNA methylation (Spiers et al., 2016; Stubbs et al.,
2017). Moreover, in this case, especially, this might be due to the presence of accidental
detection of senescence-associate beta-gal. If not in all cases, but in some cases, ageassociated glomerulosclerosis might have influenced the methylation pattern (Davies et al.,
1989; Hackbarth & Harrison, 1982). In the kidney, the positive cells had no consistent
pattern, rather scattered throughout the cortex and medulla. In some cases in brain and
kidney, positive cells were found to exist in the cluster, with having no positive cells in the
vicinity. These clusters of X-gal expressing cells might have suggested clonal expansion
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originating from a committed progenitor, of course not let alone the other possibilities. Yet,
the X-gal positive cells lied at the border of the seminiferous tubules in testes. They are
believed to be somatic Leydig cells or Sertoli cells, and need further confirmation.
However, this line is not suitable for further screening. First, it had a very low range of
detection (Fig. 2.12). For instance, the highest level of signal detected at all time point is
less than 1 per 100 cells. Second, around 90% of animals in all time points showed no
detectable values in heart, liver and lungs. Third, only one time point i.e. the aged mice
showed more number of detectable signals in most of the organs Fig. 2.13. However, this
transgenic line helped us to understand the locus dependency of expression in certain cases.
Certainly, there is an observable difference of expression between neonatal and old-time
points, at least in kidney and testes. This contrast of expression between these two
developmental time points helped us to understand the notion of age-dependent expression.
The detection values are expressed in percentage; therefore, we do believe that the low
detections in overall is not due to difference of the sections’ surface areas in between two
different time points. Finally, the cases where a detectable littermate of non-detectable
animals hinted us regarding the variation due to individual expression pattern.
However, mechanistically we tried to understand the reason behind the difference of
expression of the LacZ and LacG construct whether it is because of the methylation of the
promoter region. We did bisulfite sequencing to analyze the level of methylation present
in a part of the promoter regions of the gDNA of the mice of both lines. We found that the
promoter regions were highly methylated in both cases. More specifically, LacG had more
methylated than the LacZ line. Despite this difference, we observed some positive cells in

104

LacG line, unlike LacZ cells (Fig. 2.29). This tells us that there might be some other reason
involved in the silencing of the transgene, than the methylation alone.
Therefore we had to rely on other LacG-CGless lines, with several mapped sublines, for
the expression study. Each of these sublines has transgene placed to a unique locus point
in the genome of the mouse. Similarly to the study with the LacZ-WT, we screened the
tissues from mice of three different developmental time points. Unlike the LacZ line at a
neonatal time point, where the highest detectable value in the brain was 0.0038%, the
lowest detectable value was 0.003% for this line. Surprisingly, the highest obtained
percentage of X-gal signal in the neonatal brain for this line was 0.6% (Fig. 2.14). Although
it varied among the individual animals, the LacG071 line showed the highest expression
among all the sublines present in this LacG-CGless line. In the case of heart, although we
obtained the highest amount of expression, these signals were mostly non-nuclear
localized. This is very unusual as because the beta-gal expressed from our transgene should
be localized in the nuclear instead. However, we believe these signals are from exogenous
beta-gal, not from the counterpart, because we did not observe any expression in nontransgenic animals. Inline to support a belief, we can put forward two pieces of evidence
of the detection of L1 activity in a human sample. First, in a study in post-mortem human
heart, the presence of Orf1 protein was detected highest among the non-brain samples (Sur
et al., 2017). In another study, in an attempt of detection of full-length L1-mRNA on human
heart muscle with northern blot assay, the relative expression was found to be 200%, which
was again one of the highest detection in somatic samples (Belancio et al., 2010).
Therefore, it is evidence that mammals have LINE-1 expressed in the heart. Here although,
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the morphological entity of being expressed outside the nuclei of the cardiac cells was not
understood well.
Unlike the LacZ-WT line, liver and lungs showed detectable values, accounting for more
number of organs showing up expression at the neonatal stage. The difference of the
transgenes must be a reason why this transgene is detectable in terms of detectable positive
signals. Testes and spleen, like LacZ-WT line, however, did not show any detectable
values. This perhaps indicates further age-dependent silencing of the promoter in these two
organs.
Compared to the neonatal time point, we observed certain changes in the adult and aged
time points (for all sublines). Firstly, in comparison to the highest of neonatal brain value
(0.6%), the adult had a peak of ~2% and old animals had a peak of ~4% (Fig. 2.15 and
2.16). These three values were from three different sublines. Moreover, limited sample
number restrict us to claim a significant correlation of this upward trend with the age. High
expression levels compared to LacZ-WT line was observed. Nevertheless, this result is
consistent with another study on the human sample. In that study, a similar age-dependent
L1 activity was observed by Sur et al, where they compared the ORP1p expression among
the 15, 55, 80-year-old post-mortem human brain samples (Sur et al., 2017). They observed
almost no expression in the sample from 15-year-old; the intermediate value was obtained
from the 55-year old brain, and the highest value was obtained in the sample from 80 years
old (Sur et al., 2017). Secondly, average values dropped in case of adult and geriatric lungs
and livers from the high neonatal counterpart. However, the average values in kidneys of
adult and aged time points did not change in comparison to that of neonatal kidneys, and
values of spleen rose from undetectable to detectable during neonatal to adulthood, but no
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change was observed in old animals. In the case of testes, however, a significant increase
of values observed in transitioning from adulthood to old-time point, whereas there were
no detectable values in case of neonatal time points. It might be due to gonadotropic
hormones-regulated hypomethylation in testis, associated with the progression of the age
of the rodents (Reddy et al., 1990). Apparently, similar to adult, the tissues can be
categorized into relatively “high” (brain, heart, kidney) and “low” (spleen, lung, liver) in
old animals. Surely, a different organ-specific regulation, aided with the age factor, is
observed in all lines.
Instead of concluding the expression pattern for every line concerning age, we tried to find
out a specific organ, which is influenced mostly by different locus positioning of the same
transgene. To understand that, we tried to compare the highest average expression values
from the different organs of four (commonly used) sublines of animals of three different
time points. Notably, heart, even though having the highest expression values, were ruled
out from the test. This is because the expression pattern of heart as discussed previously is
not well understood. Therefore, we had to confine our test with only six organs in total.
Therefore, among these six organs, four organs (brain, lung, kidney and testes) had the
highest level of mean expression values. Surprisingly, kidney most frequently showed high
expression values - at least once in all three time points of the animals belonged to all four
lines. The notion of the frequent occurrence of the kidney might be comparable to that of
high expressive kidneys at the old stage of LacZ-WT strain. Similar reasons should be
echoed here. However, too little data is available on mouse kidney with a mouse-derived
promoter for supporting our finding. However, with the help of quantitative PCR (qPCR),
Kano et al measured the de novo retrotransposition in several adult tissues of L1RP mouse,
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a transgenic mouse carrying L1RP element (a highly active human L1) followed by an
enhanced green fluorescent protein (EGFP) cassette (Ostertag et al. 2000). In adult tissues
of brain, lung, liver, kidney, and tail, they found a persistent occurrence of kidney in all the
tissues (Kano et al., 2009). It is true that since this is a data from a human retrotransposon,
a little can be extrapolated about the regulation of a mouse promoter activity. Therefore, it
can be claimed here regarding our data that kidney could be a preferential place of high
endogenous 5’-UTR promoter activity in a mouse. However, further assays might be
helpful to establish this claim.
It is also should be noted as this point about three outlying values which were eventually
opted out to determine the mean value. More specifically, these all three outliers were from
old animals, and out of three, 2 of them were in kidneys of two different mice of two
different sublines (LacG071 and LacG061). Rest one value comes from the brain of
different individual animal of LacG071 subline. These outliers might have caused by the
cell-specific epigenetic dysregulation or some confounding senesce associated beta-gal
escaped from pH control due to profound presence. Regardless of high inter-individual
variation among the values, this test also empowered us to see the distribution of the organspecific quantification values. This indicated us LacG071 and LacG082 sublines as the
most and least expressive lines, respectively. Most of the sublines screened were found to
be less expressive, except LacG071. This together shows that there is a presence of locusdependent expression.
By far, it was evident that the presence of the transgene in different locus is associate with
differential expression of the promoter activity. Another line of evidence comes in favor of
locus-dependent expression when we observed a drastic change was observed when
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transgene moved from chromosome 15 (subline LacG066) to chromosome 14 (subline
LacG221) within one generation apart (Fig. 2.19). LacG066 showed the highest amount of
expression ever in its brain and kidney among all lines used for the collection of tissue
sections. Unfortunately, the line of LacG066 could not be continued, but the tissues of the
old, founder animal were collected and compared to the corresponding tissues of several
old transgenic mice of subline LacG221. In compared to LacG066, tissues from LacG221
line had sporadic incidences of expression for all organs. Although we have reported
previously the incidences, where inter-individual differences of expression were present
within an organ of an animal of particular subline and age, the ~20 fold difference in kidney
and ~4 fold difference in the cerebellum was a strong indicator of the crosstalk between
the promoters and the surrounding chromosomal environment. This certainly informs how
L1 promoters function concerning location on chromosomes.
Besides locus dependency, organ dependent promoter activity might be an obvious
phenomenon. As we have seen that LacG071 is the subline with high promoter activity in
terms of positive X-gal staining cells, we would like to take a closer look regarding the
expression pattern in the organs of it in different developmental time points. In short, we
found an organ-dependent expression differential pattern, where different organs expressed
during different time points. These organs can be categorized into three different classes,
namely ‘no’ expressing (spleen), ‘low’ expressing (liver, lungs), and ‘high’ expressing
(brain, heart, kidney, and testes) (Fig. 2.20). Similar classification can be obtained from
other LacG sublines at all points of development (Fig. 2.14 to 2.16). One of the best
examples of organ-dependent expression was observed in spleen and testes. At the neonatal
time point, the X-gal values in these organs were in the undetectable range. However, in
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the two later time points, we observed them in the detectable range (Fig. 2.14 to 2.16). We
also found that the kidney, compared to other organs, showed to as a preferential organ for
high promoter activity (Table 2.6). Overall, it indicated that there exists an organ
dependent promoter activity.
We also found an age-linked promoter activity. The first evidence was the incident when
we observe the values of neonatal spleens and testes moved from undetectable to detectable
range in later stages of development (Fig. 2.14 to 2.16). The second evidence comes when
we see that the brain showed a peak activity during adult time point among other points
(Fig. 2.22). There might be different known or unknown scientific causes to address this
observation. Here, we would like to explain this concerning the abundance of sex
hormones. There is strong evidence that sex hormones powerfully modulate the
neurogenesis in both males and females (reviewed in Mahmoud et al., 2016). For instances,
long-term exposure to testosterone increased hippocampal neurogenesis in adult male
rodents (Galea et al., 2013). Again, adult hippocampal neurogenesis was essentially found
to be regulated with estrogens (Pawluski et al., 2009). In a rat study, adults showed the
highest level of testosterone than the young and old rats (Ghanadian et al., 1975). This
suggested young rodents do not have enough sex hormone present. Evidence are there that
both sexes of rodents have drops in sex hormones are age progresses (Ghanadian et al.,
1975; Morley and Perry, 1999). It is already known also that the LINE-1 activity is a
prominent phenomenon during neurogenesis and neuronal differentiation (Coufal et al.
2009; Muotri et al. 2005). Taking together, we can support our data, saying that LINE-1
promoter activity should be highest during the period of highest neurogenesis. Sex
hormones are either not developed or its level dropped during neonatal and old-stage,
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respectively. Therefore, these two time points most likely showed low promoter activities.
On the contrary, whereas sex hormone level is at its peak during the adult stage showed
high promoter activity. The values in kidneys showed the highest variations. Both neonatal
spleen and testes did not show any promoter activity until adulthood. Unlike spleen, in the
values of testes showed an increasing trend from the adult stage to the old stage might be
based on the increased hypomethylation as stated earlier.
The brain is a classic hub of retrotransposition, where LINE-1 is present in mosaic form.
In most of the LacG sublines, except LacG071, we observed very low promoter activities
across different brain regions. In LacG071 animal model, we also saw an approximate
frequency of one X-gal positive neuron per 10000 of neurons. Besides, we observed an
age-dependent change of brain region with high expression; in some cases, a sharp rise and
fall of activity observed across different time points. For example, an elevated expression
was found in the thalamus during neonatal age, but it shifted to the hippocampus for adult
time point. In some animals of three time points, an expression pattern in the dentate gyrus
was visible (Fig. 2.23). Overall, it suggested to us that there is an observable brain-region
specific activity for our promoter, which is also age-linked.
In adulthood, the hippocampus has been reported to be associated with the neurogenesis
(Eriksson et al., 1998). The alterations to the hippocampal neurogenesis have been
observed in post-mortem tissues of patients with severe depression (Boldrini et al., 2012)
and also Alzheimer’s disease (Crews et al., 2010, Jin et al., 2004). And a higher copy
number of LINE-1 was found in the hippocampal dentate gyrus (DG) (Coufal et al., 2009;
Baillie et al., 2011). Therefore, this finding in our transgenic model is relevant to the
findings in the works of literature.
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A mouse, an exception, with very high values (>10% positive cells) showed in several parts
of its brain. This might be possible either by a persistent global hypo-methylation in all
organs or due to the effect of some unknown health issue. Alternatively, this example might
also indicate the effect of the environment on the LINE-1 promoter activity. In another
example, during the old-time points, brain expression of hippocampus and thalamus fell
from their peak state during adulthood. This is quite obvious as the hippocampus is
associated with keeping memory, and thalamus is associated with sensory integration of
information and also with alertness. Sur et al., immune detected LINE-1 activity in the
thalamus of a geriatric human (Sur et al., 2017). However, the existence of only two
samples might not tell all. Overall, during the adult time point, most of the brain regions
are elevated, and cerebellum remained with low profile among all the brain regions. Moutri
et al., observed mobility in this region for the first time. It surprised them s this area is a
non-neurogenic. A mobilization happening here would potentially be suggested that LINE1 transposition occurred in post-mitotic cells, or the cell born elsewhere but ended up
migrating to this location (Muotri et al., 2009). Another important observation is that at the
individual animal level for the adult animals, all brain regions tracked together, at a higher
range or lower range (Fig. 2.22). That might suggest that level of expression is a
characteristic at the individual level. In other words, if any mouse had high expression in a
region of brain, high likelihood that other brain regions of the same will have high promoter
activity too.
Next, we tried to find out whether any specific brain region has commonly been influenced
by the promoter activity by the different locus positioning of the same transgene. To
understand that, we compared the highest average expression values from the different
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brain regions of four (commonly used) sublines of animals of three different time points.
Among these six brain regions, four regions (hindbrain, hypothalamus, thalamus and
cerebellum) appeared with the highest level of mean expression values. Surprisingly,
thalamus most frequently showed high expression values - at least once in all three time
points of the animals belonged to all four lines. It is also should be noted at this point about
two outlying values, from a particular adult animal belonged to LacZ071, were opt out to
determine the mean values from cortex and hippocampus. These outliers might have caused
by the cell-specific epigenetic dysregulation. Regardless of high inter-individual variation
among the values, this test also empowered us to see the distribution of the organ-specific
quantification values. This indicated us LacG071 and LacG082 sublines as the most and
least expressive brain regions, respectively. This highlighted us with a clear locus-specific
expression. And the cerebellum is the lowest expressive brain region, except in one incident
of the brain of one old LacG061. This again indicates for a brain region-specific promoter
activity. This might be a cell-specific incident and can be addressed with the help of singlecell analysis.
In this study, we would like to observe how much reproducibility the transgene is expressed
when it is placed in the same genetic locus of the different mouse. On the other hand, we
also wanted to know how transgene is expressed being placed into distinct regions in
different integrant mouse lines. In the first observation, we saw that upon introducing the
transgene in the same locus, the mice were capable of producing a more or less similar
level of signals in littermates as well as in the progenies (for example, LacG072 line). We
also observed a profound gene silencing, which gave rise to the mosaic gene expression
pattern.
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The eukaryotic genome has different structural variance due to insertions, duplications,
deletions, and rearrangements. This structural variance can affect the gene expression of
the transgene (Lydiard-Martin et al., 2014). Chromosomal localization of transgene at the
proximity to centromere or any other heterochromatic region may contribute to the gene
silencing. Chromosome locations which promote transgenic expression are considered as
the transcriptionally active sites of euchromatin. The heterochromatin sites are inaccessible
to the transcription factors and are often correlated with cytosine hypermethylation and
also with histone hypoacetylation (Ng and Bird, 1999). As the heterochromatin integrate
itself to the proximity of this chromatin architecture, it shows the variability of the
transgene expression (Dobie et al. 1996; Iglesias et al. 1997). Moreover, the neighboring
regulatory elements at the site of insertion can silence or modulate the expression of the
transgene in mice (Hatada et al., 1999; Al-Shawi et al., 1990).

It is common that different transgenic mouse same transgene exhibit different pattern of
expression. Position effect variegation is rather a common phenomenon that is responsible
for sectoring of gene expression patterns in both amounts and tissue specificity. It is a
common term concerning transgene silencing in a mouse model (Dobie et al., 1997). It is
a position-dependent silencing of the transgene in a fraction of cells that lead to forming
tissues, where these cells continue to inherit this trend to the daughter cells. Therefore, the
tissue shows a variable and mosaic pattern of transgene expression. This stochastic
silencing of the transgene is mostly caused by different mechanisms, such as chromosome
localization of the transgene, transgene copy number, DNA methylation, aggregation of
multiprotein complexes at the promoters with repeated sequences, etc. However, the effect
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of variegation is difficult to detect in the tissues of the immune system and brain. This is
because in these tissue the daughter cells happen to migrate following cell division.
(Mentioned in Dobie et al., 1997).
In two mice studies, the evidence of position-effect variegation was observed. First, in two
of the 3 sublines of a transgenic mouse line, of variable positioning of the transgene (with
beta-1actoglobulin (BLG) transgene), showed up to ten-fold inter-individual differences in
transgenic expression within the individual mice (Dobie et al., 1996). In another example,
in situ staining of the sections of thymus from transgenic mice carrying a human CD2
transgene showed some clustering of transgene expressing cells (Festenstein et al., 1996).
However, these observations point to that individual cells could able to suppress the
transgenic expression and also can propagate the inactive state through cell division, which
might lead to mosaic or variegated expression patterns.
Another possibility with the silencing is the position-effect model, which is similar to PEV
but involves the spreading of the heterochromatin region to the gene or integration of the
locus into a heterochromatin complex in the form of loop (Wakimoto 1998). However,
there could be many unexplained reasons for this variation in transgenic mice (Jetton et al.,
1994; Hennighausen et al., 1995).

2.5.1 Overall conclusion
This study helps us to understand many fundamental locus-specific and organ-specific
regulation of promoter activity in vivo. However, the exact mechanism was not known very
well. It is believed that the major factor of the differential expression is because of the
positioning of the transgene in the chromosome (Shaw-White et al., 1993). Promoter
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occlusion could be one of the reasons for the variability of expression due to the position
effect.
The striking thing that was observed here is the organ-specific regulation i.e. in some lines
activity was low and in some lines, activity was shown to be higher, so much so we could
categorize the organs based on the level of promoter activity. As we have observed gene
silencing in most of the loci, we can extrapolate that the phenomena of position effect are
a ubiquitous characteristic for the given transgene in the same genetic background.
Age-dependent change of promoter activity was observed. For example, in spleen and
testes, the activity was critically low in neonates but was detectable in later stages. In
LacG071, we showed how promoter activity in the brain (Fig. 2.22) showed an
individualized pattern as we observed in some animals. An animal showed high expression
in one part of the brain, continued showing higher expression in other parts as well. Also,
in rare cases, some animal showed a very high level of expression persistently in most of
the organs.
However, the exact factor controlling the transgenic expression was not understood.
Therefore, further studies with transgenic mouse having a targeted placement of the
transgene at a chose locus was necessary to observe a stable expression if any (Jasin et al.,
1996; Wallace et al., 2000). The technical caveat of this study was included, low small
sample number, presence of high variability of the signal quantification. This expression
pattern has relied on one type of LINE-1 promoter.
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Chapter 3
Specific locus- and orientation-dependent LINE-1 promoter activity

3.1 Abstract
Randomly integrated transgenes are prone to gene silencing, while targeted delivery of
transgene to a chosen locus in the mouse genome has few advantages. Therefore, the
transgene was targeted to Rosa26 locus, which is well known for giving higher expression
in different animal models. To characterize the orientation-dependent expression of the
endogenous LINE-1 promoter, we also orientated in two different directions and created
two gene-targeted mouse lines: sense and anti-sense. We observed a thousand-fold higher
expression in the anti-sense orientated form, unlike the sense oriented promoter.
Expression from the sense oriented form is believed to be affected by the transcriptional
interference from upstream Rosa promoter that might have led to read-through
transcription that interfered with transcription initiation from the transgene promoter. No
age-dependent difference in expression in the anti-sense line was observed, except in the
cerebellum. In short, this orientation-dependent expression also indicated how an inversely
placed LINE-1 insertion would be expressed in vivo in mammals.

3.2 Introduction
Gene silencing can be experienced by the introduced transgene in a random location of the
genome of the host animal (Clark et al., 1994). Most of the mechanisms are unknown for
this silencing, but two of the prominent reasons can be the status of the chromatin landscape
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of the site of the host genome and the copy number of the introduced transgene (Clark et
al., 1994; Dorer, 1997; Garrick et al., 1998). The consequences of this silencing can be
either in mosaic expression, which might indicate a progressive silencing, or the complete
shutdown of the transgene’s overall expression (Martin & Whitelaw, 1996).
In this occasion, to avoid this silencing effect, a preferred chromosomal site can be chosen
in the mouse genome (Misra & Duncan, 2002; Bronson et al., 1996). This approach can
also give some of the added advantages. First, a favorable chromosomal site for a consistent
expression may help to avoid the possibility of undesirable insertional mutagenesis.
Second, the transgene can be introduced in a single copy to exclude the problems associated
with large tandem repeats.
One of such chromosomal locus for ubiquitous expression can be found in mouse
chromosome 6 (Zambrowicz et al., 1997). This locus is known as Gt(ROSA)26S or Rosa26
locus. Since the Rosa26 locus is mostly active in most of the cells or organs, any genetic
sequence inserted into this locus must not be shut down for its expression by chromatin’s
unfavorable configurations. Therefore, this locus position is often used to express
endogenous sequences, and often for a reporter sequence attached with an endogenous
promoter (Soriano, 1999; Mao et al., 2001). In addition, the promoter present on the
Rosa26 locus can also be applied to drive a widespread expression of reporter genes in
transgenic mice and rats (Awatramani et al., 2001). In these animal models, a ubiquitous,
stable expression out of a single-copy transgene, being at this locus, can be utilized for
lineage-tracing experiments in different stages of development (Soriano, 1999).
In the earlier chapter, the expression from the transgene construct was checked by inserting
LacG transgene in several random chromosomal sites. The neighboring regulatory
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elements at the site of integration of this transgene might have played a vital role in
modulating the expression (Hatada et al., 1999; Al-Shawi et al., 1990). In this study, to
eliminate the influence of this factor on the expression, the same transgene construct was
inserted into the Rosa26 locus by targeted recombination, in order to test if the Rosa26
locus would affect transgene expression (Fig. 3.1). This will help us to understand whether
the placement of transgene at a specific chromosomal address expressed in the same
manner in vivo or more organs.
Notably, two ideas are important to understand at this stage as well. Firstly, it is also known
that the position effects are influenced by the orientation of a transgene with respect to
flanking chromatin (Feng et al., 2001). Secondly, in a human genome, in addition to senseoriented transcripts, antisense transcripts are produced by the anti-sense promoter present
in the human 5’-UTR promoter, and nearly one-third of the human LINE-1s possess active
anti-sense promoters (Speek, 2001). It might be very obvious that some of these antisense
promoters are translated. These antisense transcripts also have regulatory roles; one of them
is the base pair formation with the sense-oriented transcript in order to form a dsRNA
substrate for the Dicer protein for degradation (Levin et al., 2011). On the other hand, it is
already known that anti-sense oriented insertion is prone to produce truncated transcripts
with premature polyadenylation (Han et al., 2004). It is also reported that antisense
promoters can act as an alternate promoter of the neighboring sequencing, deriving the
formation of chimeric mRNA, which, again, interfere with the regulation of the adjacent
genes. In humans, these anti-sense promoters have locus-dependent activities (Matlik et
al., 2006). In contrast, LINE-1 insertion in a sense orientation is rather rare in the proteincoding gene in the human reference genome (Ewing and Kazazian, 2011). However, they
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are more detrimental to a gene because RNA polymerase II strives hard to process the sense
oriented LINE-1 insertions (Chen et al., 2006; Han and Boeke, 2004; Han et al., 2004).
Therefore, we see that LINE-1 insertions in both orientations are dissimilar based on the
differences of their actions and regulations. Therefore, it vital to characterize how mouse
5’UTR LINE-1-promoter activities are expressed in sense and anti-sense being in the same
locus to better understand the endogenous regulation of LINE-1 promoters.
Hence, taking the above-mentioned points in the account, we systematically varied the
orientation by letting the transgene integrate in sense and inverse orientations into the
Rosa26 locus, and thus generated two independent mouse lines, namely sense and antisense
lines. They will allow us to assess the effect of the construct’s orientation for the integration
site.

3.3 Materials and Methods
Ethics statement
The study was carried out under the strict accordance with the guidelines provided by the
National Institutes of Health in the Guide for the Care and Use of Laboratory Animals. The
protocols were thoroughly approved by the Institutional Animal Care and Use Committees
(IACUC).

Mice
WT and transgenic mouse lines were maintained in the C57BL/6J (B6) background. Mice
were housed in well-ventilated cages. In maximum, up to five adult mice per cage was
allowed. They fed on quality-controlled standard pellet chow and pure water ad libitum in
a regular 12-hour light/dark cycle at room temperature. Rosa26 sense and Rosa26 antisense
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lines were produced with gene targeting (homologous recombination) method by Cyagen
Biosciences Inc., US.
Cryosectioning and X-gal staining of fixed tissue
Mostly the same as Chapter 2. But the X-gal staining duration was re-optimized for Rosa26
antisense line.

Tissue harvesting and preparation
Same as Chapter 2

Statistics
Statistical analysis and mathematical calculations were performed using either Microsoft
excel. Sample means were compared with the help of two-tailed unpaired T-test used and
expressed in terms of the p-value. Analysis of replication consistency was tested with
Coefficient of variation (CV%) was used to analyze replicate consistency. Any CV values
with <100% were regarded as with a lesser variation.

Genotyping PCR
Genotyping of the mice was performed with gDNA mainly from their tail biopsies. A PCR
reaction using ExTaq or ExTaq HS polymerase was run for the detection of the presence
or absence of expected transgene with the set of specific primers (Table 3.1).
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Line
Mov10L1+/-

Primer pairs
WA549 & WA550

WA567& WA568
Rosa26 sense

Rosa26
antisense

Expected band
461 bp
(Transgenic
band)
398 bp (WT
band)
Mutant= 373bp
WT= na
WT=617bp
MT=335bp

PCR protocol

Genotyping PCR

Region 1
Rosa26 genotyping
WA1550, WA1555
PCR protocol:
Region 2
C
min/s
WA1551, WA1552,
3min
94
WA1553
30
94
Region 1
Mutant= 476bp
35
62
WA1550, WA1554
WT= n/a
35
72
Region 2
WT=617bp
5min
72
WA1555,WA1552
Mutant=348bp
WA1553
Table 3.1 Genotyping protocols for two transgenic mouse lines.
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Microscopy and image analysis
Same as Chapter 2

QuPath
Same as Chapter 2

QuPath Data Plot
Same as Chapter 2

3.4 Results
3.4.1 Unlike Rosa26 sense line, Rosa26 antisense tissues needed further optimization
due to high abundance of the signals

At the outset, the same X-gal staining protocol as mentioned for the genotypes in Chapter
2 was adopted.

However, excessive staining was obtained for the anti-sense line.

Therefore, to restrict the excessive staining, which might interfere with the quantification

127

of the signals, we had to reoptimize the staining time for Rosa26 antisense animals only,
depending on the age of the animals. For adult tissues, time was reduced to 45 minutes for
brain sections (Fig. 3.2.1a) and 120 minutes for other tissues (Fig. 3.2.1b) using a standard
concentration of X-gal (25mg/ml). For neonatal tissues, the optimal staining of all tissues
was obtained with a lower concentration of the X-gal compound (6.25mg/ml) for 4 hours
(Fig. 3.2.2). Figure 3.3 shows the typical staining patterns of these two lines in the
hypothalamus of neonatal mice.

Figure 3.1. Two different orientations of the promoter targeted into the Rosa26 locus.

1. Adult tissues of Rosa26 anti-sense line
(a) Brain (Cerebellum)
45 mins incubation with X-gal 25mg/ml
3 hours incubation with X-gal 25mg/ml

Saha042

Saha042
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(b) Kidney
120 mins incubation with X-gal 25mg/ml

3 hours incubation with X-gal 25mg/ml

Saha042

Saha042

2. Neonatal tissues of Rosa26 anti-sense line
Brain (Thalamus)
4 hours incubation with X-gal 25mg/ml
Overnight incubation with X-gal 25mg/ml

Saha088

Saha088

Figure 3.2: Optimization of staining condition for Rosa26 antisense line. 1. Adult time
point in brain and kidney 2. Neonatal time point in the brain.

Rosa26 sense (S030), Brain (Thalamus)

Rosa26 sense (S063), Brain (Thalamus)
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Figure 3.3: Desired staining patterns matched with their corresponding the two
genotypes used in this study.

3.4.2 Promoter orientation altered the level of expression: Rosa26 antisense had
1000 fold more expression than the Rosa26 sense line
In the Rosa26 antisense line, a high X-gal expression was observed in all organs.
Approximately, more than 10% of cells in all organs showed to possess positive staining.
However, exceptionally, in few cases in lungs and spleen had low expression. In the heart,
similar to the random lines, non-nuclear localized positive signals were observed.
In this Rosa26 sense line, most of the expressions are undetectable. However, a few
detectable positive signals have been identified in brain and kidney of neonatal time points.
Similar to the neonatal situation, at the adult stage, detectable signals were identified in the
brain, lungs, and testis. Although, the organ with the highest detectable positive signals
was carrying a significantly low percentage of positive cells (less than 0.1%). In both of
the lines, approximately, there is a 1000 fold difference in the level of expression between
Rosa26AS and Rosa26S. The expression (Fig. 3.4) was compared between two different
time points i.e. the neonates and adults of Rosa26AS and Rosa26S lines.
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a.

b.
Figure 3.4 The difference of expression of two gene-targeted lines at two different
time points. (a) The orientation-dependent difference of expression, (b) age-dependent
difference of expression
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Sample images:
(a) Antisense line

Saha102 (Kidney)

Saha102 (Brain)

Saha100 (Heart)

Saha013 (Brain)

Saha100 (Lung)

Saha063 (testis)

(b) Sense line

Saha156 (brain)

Saha156 (kidney)
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Saha157 (Heart)

Saha028 (Brain)

Saha156 (Lung)

Saha155 (testis)

Figure 3.5 Sample images from Rosa26 anti-sense (a) and sense lines (b). (Note:
some regions are zoomed in to show the contrast/pervasiveness of the expression).

3.4.3 There is developmental time-dependent brain expression in brain regions of
Rosa26 antisense line
In the Rosa26 anti-sense line, for both of the time points, expressions were very high
(Fig. 3.6). In an average, ~13.35% cells are X-gal positive at neonatal time point.
Among these values, the thalamus has the leading expression. In neonatal time point,
unlike others, the cerebellum has statistically significant (p value= 0.037968)
difference between both time points of neonatal and adult within the given set of sample
number. On the other hand, in the adult time point, the number of positive cells
decreased to less than 10% averagely (6.65%). At the same time, the thalamus values
specifically fell to approximately 1% (0.68%).
In Rosa26 sense line, most of the signals are undetectable (Fig. 3.6). At the neonatal
time point, the hypothalamus was a region with high positive signals, but this region
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went undetectable in case of the adult time point. The hindbrain showed detectable
range in both neonatal as well as in adult time points.

Figure 3.6 The orientation-dependent expression differences of the transgene at two
developmental time points.

3.4.4 Transgene in Mov10L1 knock out mouse background did not show overexpression of promoter activity in testis of Rosa26 sense line
To look for whether the hypermethylated transgene promoter can over-express promoter
activity in the hypomethylated background. We observed that sense-line in Mov10L1 KO
background did not produce and signal. Only a few basal cells in the seminiferous tubules
expressed promoter activity.
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Saha252

Saha258

Figure 3.7 Promoter activity in testis of Rosa26 sense line in a Mov10L1 KO
background.

3.5 Discussion
To rule out the influence of integration site and variable copy number on the expression
pattern of the transgene, we knocked it in single copy into a specific locus, Rosa26. At the
outset, we had two choices of favorable chromatin loci for ubiquitous and stable
expression, namely HPRT locus and Rosa26 locus. As the HPRT locus is located on the X
chromosome, the expression is subject to random X-inactivation, or in other words, the
expression would be guaranteed only in case of homozygous females. Moreover, the
evidence is there that even in that case too, expression in certain tissues, like kidney and
liver, are low and sometimes undetectable (Bronson et al., 1996; Hatada et al., 1999).
Therefore we had to opt for the alternative choice i.e. Rosa26 locus. This has been widely
used for favorable gene targeting site in mouse (Friedrich & Soriano, 1991; Srinivas et al.,
2001; Nyabi et al., 2009). In addition to the use in mouse, this chromosomal site has also
been used for traditional homologous recombination in humans and rats (Irion et al., 2007;
Kobayashi et al., 2012). This also suggested that this site has limited inter-species
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variability for stable expression. This ubiquitous expression also suggested that the
transcriptional activity is less likely influenced by the chromatin configurations, which
sometimes offer transcriptional repression through several regulatory elements in the
flanking chromatin landscape. Whatsoever, we targeted our LacG transgene into this locus
for a reliable expression pattern.
Similar to as described in Chapter 2, we stained the fixed tissues with X-gal from the mouse
at two time points: neonatal and adult. At first, we attempted to keep the X-gal staining
time same for the random lines and these two targeted lines. Upon staining the tissue for
regular length of time, we observed a dark, heavy, diffusible stains only in the anti-sense
line. It was unrealized until then that the blue compound as a product of the enzymatic
reaction is, however, diffusible in fixed tissue and could eventually blur the distinctions
between the nuclear and cytoplasmic signals (Sanes et al., 1986; Gray et al., 1988; Weis et
al., 1991). Overall, this the problem became apparent when we stained the samples from
the Rosa26 antisense line with the optimized X-gal staining condition used in Chapter
2. The heavy blue stains darkened the sections, and almost completely masked the neutral
red co-stains. Co-localization of both of the signals, where applicable, was needed to
determine the total fraction of transgenic positive cells within the whole population of cells,
which was determined by the total number of neutral red-stained cells. Therefore,
strategically, we had to shorten the duration of X-gal staining for the Rosa26AS genotype
so that we have distinct nuclear-localized signals to represent the total number of transgene
positive cells.
In the revised protocol, we still observed a pervasive X-gal staining in most of the organs
of heterozygous antisense animals, whereas we found almost no staining in the
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cryosections of sense line. An estimation of the difference was 1000 fold between these
two lines. Notably, the highest value of signal quantification if the Rosa26 sense line is
0.1%, whereas the estimated average signal quantification of Rosa26 sense line was around
10%. This is the novel approach where endogenous LINE-1 promoter was ever targeted
into Rosa26 locus. Therefore, no data related with this transgene construct being targeted
in this specific locus or other related loci was available to understand the mechanisms of
silencing of the Rosa26 sense oriented promoter and the same of heavy staining of the antisense oriented promoter.
However, a similar study was performed using the same reporter in HPRT locus by Stringer
and colleagues (Shaw-White et al., 1993). There they observed a similar contrast between
two orientations of LacZ transgene targeted into the HPRT locus. In that study, they
targeted a LacZ gene, under control of an SV40 promoter, to the HPRT locus in ES cells.
The expectation was that, since HPRT is a 'housekeeping gene' and is expressed
constitutively in all cell types, LacZ would be ubiquitously expressed. The targeted ES
cells, all of which expressed LacZ in culture, were injected subcutaneously into syngeneic
strain 129 mice and allowed to grow into tumors containing multiple differentiated tissue
types, which were then stained for beta-gal galactosidase activity. Targeted cell lines with
LacZ in inverse orientation to the direction of HPRT gene transcription expressed high
levels of beta-galactosidase in epithelial cells. However, targeted cell lines containing a
transgene oriented in the same direction as the HPRT gene transcription did not express
high levels of LacZ in any differentiated cell type. Analysis of transcripts suggested that
this orientation effect may have been the result of transcriptional interference perpetrated
by the HPRT gene promoter. Cell lines in which LacZ was oriented .in the same direction
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as HPRT contained RNA transcripts that appeared to originate from the HPRT promoter
and proceed through the transgene’s promoter and the LacZ coding region. These RNAs
would not be expected to be capable of producing an HPRT-beta-galactosidase fusion
protein because of the presence of a stop codon in between the HPRT open reaching frame
(ORF) and the beta-galactosidase ORF. Some direct-orientation cell lines contained no
detectable 3.3 kb transcript. It might be possible that the low abundance of the 3.3 kb
transcript in these cell lines was due to read-through transcription interfering with
transcription initiation from the transgene promoter (Shaw-White et al., 1993). Notably,
inconsistent with their result, in our result too, the quantified expression values from the
sense line is lowest in compared to the randomly integrated lines (with intermediate values)
and antisense line (with highest) values of expression.
In In this present study, we also predict that similar mechanisms of transcriptional
interference might have taken place, completely ruling out the trivial possibility that the
plasmid was constitutively defective for expression of beta-galactosidase because 3T3 cells
transfected with this DNA were positive in the X-Gal assay. Overall, this might be the
reason for how around 10% of all organs showed positive staining in the antisense line.
Unstained cells in the organs of Rosa26 antisense, along with the lowly expressed organs,
like lungs and spleen, might have different cell-specific or organ-specific regulations which
restricted the transgene expression. These types of regulation can be due to tissue-specific
and developmental stage-specific transcription factors, like auxiliary proteins and DNAbinding sequence-specific transcription factors or host epigenetic factors. Any of this kind
of mechanism either have gone loosen or restricted at the cellular or organ levels mouse of
either of the developmental time points. Matlik et al., showed that there are a locus-
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dependent and tissue-specific expression pattern of antisense promoter’s activity in human
in vivo. There, they have demonstrated that LINE-1 ASP antisense promoter (ASP) is
active in a wide variety of normal human tissues, but L INE-1 ASPs at defined loci are not
active in all tissues (Matlik et al., 2006). There they explained that varies based on minimal
sequence divergence and differences in their epigenetic state. In this case, we explain our
case with the latter phenomenon as the probability of the former case is null.

It is also possible that the lack of expression in these cells could have been due to a silencereffect exerted by the 5'-end of the Rosa26 segment juxtaposed to the transgene gene.
However, the activity of such a hypothetical cis-acting a silencer would be necessarily
conditional in two ways. Firstly, it would be inactive in cells in which LacZ expression
was observed. Secondly, it would be inactive when located downstream of the transgene.
In heart, we have not found any nuclear-localized signals like that we saw in chapter 2.
However, we believe that these are real signals as we did not obtain any signals in transgene
negative animals, but we cannot give any explanation to the cause of these signals of this
shape.
Since we see the brain is an important site with adequate expression in random lines, we
took a closer look at the brain in Rosa26 antisense and sense lines. In Rosa26AS, overall
we observed a consistent high expression in both of the developmental time periods.
However, compared to the neonatal time point, we observed a region-specific fall of
expression, particularly in the thalamus at adult time point. This observation is just opposite
to what we observed in the highly expressed line, LacG071, of random lines. However, it
is difficult to conclude on this due to the small sample number. Here, we also observed an
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overall fall in the total number of X-gal positive signals from neonatal time point to
adulthood. This might be due to age-dependent phenomena combined with the intrinsic
characteristic of this locus for this promoter. However, among all regions, the only agedependent difference in expression in the cerebellum was showed significant statistically
in the given set of data (however, this significance might not be staying upon increasing
the sample numbers). This might tell us that some other factors might be involved in case
of regulation of transgene in inverse orientation, which might determine which cells have
high levels of beta-galactosidase, and which cells do not. As we know that different regions
of the brain nurture more or less particular types of brain cells, and with the progression of
age, these type of cells either differentiate into other types or degenerate. Therefore, this
age-dependent the difference in expression in cerebellum might hint us regarding a cell
type-specific expression, and also expression variegation, where expression of betagalactosidase varied within a population of cells of one type. In the next chapter, we will
show how we attempted to differentiate these cell types which particularly held an
expression of the antisense-oriented transgene. On the contrary, as like most of the organs
in the Rosa26S line, brain regions in the same line are mostly silent. Any occasion of
expression in certain regions can be called as a rare cell-specific incident and could be
explained appropriately by analyses at the single-cell level.
Human LINE-1 promoters are bidirectional, containing a sense promoter responsible for
transcription within the LINE-1 element and an antisense promoter (LINE-1 -ASP) that
can drive transcription of adjacent regions giving rise to transcripts composed partly of
LINE-1 and partly of genomic sequence (LINE-1 chimeric transcripts (LCTs) (Speek,
2001; Cruickshanks & Tufarelli, 2009). Recent evidence suggests the existence of a causal
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link between aberrant activation of individual LINE-1-ASP promoters and cancer
development and progression (Weber et al., 2010; Wolff et al., 2010).
Our result highlighted that anti-sense promoter activity is thousand fold higher in compared
to sense orientation being positioned in a permissive locus, like Rosa26. In type of cases,
more active promoters (in this case Rosa26 promoter), in the upstream, may act as an
alternate promoter to form a read-through transcript and ultimately leading to suppression
of the sense oriented LINE-1 promoter to form transcript from ORF1 & 2 sequences. On
the other hand, the anti-sense promoter can be unaffected. Overall, this reflected how the
sense and antisense promoters, being inserted into a permissive locus may behave.
A probability of a certain level of methylation-dependent gene repression is always there,
regardless of the chromosome position. In case of any hypomethylation-induced activation
of LINE-1-ASP promoters can further drive the transcription of cancer-specific LINE-1
chimeric transcripts (LCTs) transcribed in the same (sense) or opposite (antisense)
orientation with respect to the neighboring genes (Cruickshanks & Tufarelli, 2009). In
another instance, it is evidenced by weber et al. that demethylation of a LINE-1 antisense
promoter in the cMet locus impaired Met signaling through induction of illegitimate
transcription (Weber et al., 2010). Although the methylation of the promoters was not
checked, yet it is believed that on being hypomethylated this antisense LINE-1-prompter
can bring a synergistic effect in terms of intense transgenic expression. Knocking out the
piRNA-DNA methylation pathway leads to DNA methylation at LINE-1 Promoters and
thus it led to 70-fold increase in retrotransposition in postnatal germ-cell development in
mouse with a 5′UTR-ORFeus transgene (Yang & Wang, 2016; Newkirk et al., 2017).
Therefore, we bred a piRNA KO (Mov10l1−/−) mouse with LacG oriented in sense line.
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Although we could observe a spermatogenic failure in the germ-lines. However, we could
not see any increased expression of promoter activity (Fig. 3.7). This might indicate that
prevalent RNA interference, but not the demethylation is responsible for the lower number
of positive cells.

Overall, we found that there is an orientation-dependent expression of our transgene
construct being targeted into the Rosa26 line. This finding is consistent to an earlier
observation, however, in cell lines, where CMV the driven expression of the reverse
tetracycline transactivator (rtTA) at the Gt(ROSA)26Sor locus was inferred to be more
robustly expressed in the antisense orientation (Strathdee et al., 2006). Besides showing an
interesting expression of our transgene in Rosa26 antisense orientation, the non-expression
from the sense orientation at the same time, also, reminded one of the limitations of gene
targeting in Rosa26 locus i.e. transcriptional interference from upstream promoter
sequences (which can be limited by the use of an insulator element). Other limitations of
the general application of this method with respect to exogenous promoters have essentially
limited by the transcriptional complexity of the Rosa26 locus (Zambrowicz et al., 1997)
and of course a lack of systematic studies.

3.6 Conclusion
To rule out the effect of the flanking chromosome site on the transgene expression, we
were able to gene target our LacG transgene in two orientations into a specific locus,
Rosa26, which is well known for a ubiquitous expression in different transgenic animals.
In this case, we were able to show that the same transgene show contrasting orientationdependent expression pattern in two lines. This again proves that the surrounding
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chromosomal landscape was a prominent determining factor why promoter activity is
repressed in randomly integrated lines and also provides the necessary evidence that
endogenous LINE-1 promoter in anti-sense orientation might have a profound expression
in the mammalian genome.
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Chapter 4
Cell-specific LINE-1 Promoter Activity

4.1 Abstract
The mammalian brain is composed of different types of cells, which can be classified based
on their functions. Previous chapters showed brain-region specific promoter activities. This
possibly indicated a physiological role of the LINE-1 activity in the mammalian brain. It
is assumed that identification of the cell types, carrying the promoter activity would be
helpful to reveal the role of LINE-1 on neurophysiology. Therefore, this chapter aimed to
identify the major brain cells that hold the promoter activity in terms of transgene
expression. In this study, six different brain cell-markers were used to detect several
neuronal, macroglial, microglial, and stem cell types. A fluorogenic substrate was used to
replace the X-gal compound for detecting the promoter activities. At the same time, an
automated, quantitative signal detection approach was also implemented for the detection
of the percentage of brain cell types holding the promoter activity in a specific brain region.
Although all the brain markers were successfully detected, yet a contradictory background
problem due to the use of fluorogenic substrate halted the progress. An alternative approach
can be realized to complete the entire plot.

4.2 Introduction
It has been a while that we are aware that retrotransposition activity presents a formidable
threat to the host genome. They are involved in causing several heritable and inheritable
diseases in mammals, including humans (reviewed in Saha & An, 2019).
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A systematic spatial and temporal control of gene expression is an essential part of
biological processes, like proliferation, apoptosis, development, differentiation and aging.
In a different type of cells, these regulations are specifically maintained by a class of gene
regulatory elements, known as enhancers. These enhancers are a short sequence of
approximately 1 kb long located either upstream, downstream or inter-introns, can harbor
specific transcription factors to produce a cell-specific expression pattern (Levine, 2010;
De Laat and Duboule, 2013). Despite our advanced knowledge in the retrotransposon field,
our understanding is still extremely limited on how LINE-1 activity is determined by these
type of cell-specific regulations – and at least, which cell types promote or suppress
retrotransposition activity.
So far, we established that individual LINE-1 promoters exhibit both loci- and tissuespecific activation, which is also orientation dependent. This implied that LINE-1 promoter
activity originates from some permissive loci and also suggesting that a new layer of celltype-specific regulation that controls endogenous retrotransposons.
Over the past years, LINE-1–EGFP reporter system had been successfully utilized in
animal models to elucidate the effect of LINE-1 mobilization in age-dependent
neurogenesis, suggesting the brain as a hotspot for LINE-1 mosaicism (Coufal et al., 2005;
Muotri et al., 2005; Garcia-Perez et al., 2010). Our studies in the past two chapters showed
a substantial expression at the brain level, and interestingly in specific brain regions. These
prompted us to translate our approach to determine the brain cells specific to hold the
promoter activity. Therefore, in the present study, we tried to determine which brain cell
types mostly held the LINE-1 promoter activity is mostly expressed random line and other
two different gene-targeted lines.
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4.3 Materials and Methods
Ethics statement
The study was carried out under the strict accordance with the guidelines provided by
National Institutes of Health in the Guide for the Care and Use of Laboratory Animals. The
protocols were thoroughly approved by the Institutional Animal Care and Use Committees
(IACUC).

Mice
Same as Chapter 2

Tissue harvesting and preparation
Same as Chapter 2

Cryosectioning
Same as Chapter 2
Note: Tissues were sectioned in a thickness of 14um for immunostaining.
Immuno-staining followed by containing Res-gal staining with secondary antibody
Brain sections were obtained in 14um thickness. Immersed in 1XPBS for 10 minutes.
Rinsed with water briefly. Incubated at RT with 1xPBS with only 0.3% TritonX100 for 5
minutes 3 times. Blocked for 2 hours at RT with a blocking buffer, containing 0.3% Triton
X100 in 1XBPS and appropriate serum. Except the case of using anti-mouse primary
antibody (used 1% BSA), blocking buffer in all other cases was containing 5% donkey
serum. Overnight incubated with a blocking buffer with a required ratio of primary
antibodies. Incubated at RT with 1xPBS with only 0.3% Triton X100 for 5 minutes for 3
times. The secondary antibody in appropriate conc., containing 1mM Res-gal for samples
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of Rosa26 antisense line and 2mM for the samples of random lines, was used to incubate
at 37C for 1 hour. Incubated at RT with 1xPBS with only 0.3% TritonX100 for 5 minutes
for 3 times. Incubated for 5minutes with DAPI. Incubated at RT with 1xPBS with only
0.3% TritonX100 for 5 minutes 3 times. Rinse with water. Mounted with 1%PVA before
putting on coverslips. Note for the procedure to prepare 2nd dilution: Prepared 1M Res-gal
stock in DMSO. The appropriate volume of Res-gal was added to a solution, containing
10M MgCl2 and 0.3% of TritonX100 in 1XPBS. Vortexed vigorously for 2 minutes.
Centrifuge for 1 minute at 14000 rpm. Pipette out the supernatant and add the appropriate
volume of a secondary antibody. Did all steps in the dark as Res-gal is light-sensitive.

Chemical/ Reagents

Manufacturer

Specification

Res-gal (Resorufin Beta-Dgalactopyranoside) MW 375.33

Marker Gene

Ref.: M0203
Lot: 286JJN009

Primary Anti-bodies
Mouse anti-GFAP (1:1000)

Sigma

Rabbit Anti-NG2 (1:500)

Millipore

Goat Anti Sox2 (1:100)
Rabbit Olig-2 (1:1000)

Santa Cruz
Millipore

Rabbit Anti-NeuN (1:1000)
Rabbit Anti-IBA-1 (1:150)

Abcam
Wako

Ref: G3893
Lot: 056M4864V
Ref: Ab5320
Lot: 251778
Ref: SC-17320
Ref: AB9610
Lot: 2728398
Ref: AB177487

Secondary antibodies
Donkey Anti-goat Alexa fluor 488
Jackson Lab
(1:1000)
Donkey Anti-rabbit Alexa fluor- 488 Invitrogen A21206
(1:500)
Donkey Anti-mouse Alexa fluorInvitrogen A21202
488
(1:1000)

Ref: 019-19741

Ref: A-705- 645 147
Lot: 2045215
Lot: 1305303
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Donkey Anti-rabbit Alexa Fluor 594
(1:500)
4′,6-diamidino-2-phenylindole
(DAPI) (1:1000)

Invitrogen A21207

Lot: 567297

Thermo Scientific

Ref.: 62248

Fisher Bioreagents

CAS 9048-46-8

Dimethyl Sulfoxide (DMSO)

Lampire Biological
Laboratories
VWR Life Sciences

Molecular Biology grade water

Hyclone

Cat.# 7332100
Lot: 13A29004
CAS 67-68-5
Lot: 19C2656019
Cat SH30538-02
Lot: AAC200214

Other reagents
Bovine serum albumin (heat-shock
treated)
Donkey serum

Confocal microscopy
The confocal microscopy of the immunostained microscopic slides was taken with the help
of Olympus FV1200 Scanning Confocal Microscope (x20 dry) based at the Functional
genomics core facility at South Dakota State University. The images were analyzed by a
software Fluoview Fv1000. Samples were excited at 488 nm (Alexa Fluor 488), 405 nm
(DAPI), 568 nm (Res-gal) and the emission light was collected at 520 nm, 461 nm, and
559 nm for each of these channels, respectively. Z-stack images of approximately 4 μm
thickness were taken for each sample at 3 μm step sizes. Each frame consisted of a 1024 ×
1024 pixel image, captured at a rate of 20 μs/pixel.
The confocal images were further analyzed with the help of image J software (version
1.52p). In total, nine stacks from each of the three channels (with 3 stacks per channel)
were stacked individually after adjusting for the parameters, like brightness and Z
projection (type: “Max intensity”). Later, the three stacked images for each channel were
merged and was saved as .tiff file. This image was fed in QuPath for the quantification of
cells with signals.
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QuPath: quantification of signals
Two image types in the program QuPath were used for quantification: brightfield (H-DAB)
for X-gal stained tissues and fluorescence for immunofluorescence tissues. For the X-gal
stained tissues, a different script was created for each tissue based on its specific
characteristics. Each script was modified using a certain number of channels. Each channel
denoted a specific command to either denote a cell as either positive, negative, or border
based on the intensity of the hematoxylin or DAB. The mean, sum, and max intensity of
these two parameters were optimized over a range of several tissues to accurately detect an
X-gal positive cell from a negative. A percentage was then derived by taking the number
of positive cells divided by the number of negative cells plus positive cells and then
multiplied by 100. The cells detected as border were determined to be falsely detected cells
and were not included in this equation. Immunofluorescence followed this same protocol,
but channels were focused on FITC, DAPI, and Res-gal instead of hematoxylin and DAB.

4.4 Results
In this experiment, we attempted to co-stain five brain cell markers (NeuN, Olig2, NG2,
GFAP & Sox-2), along with Res-gal and DAPI on the same section on the same tissue
section. These tissue sections were from animals of random lines as well as Rosa antisense
lines. N804 is an animal belonging to the highest expressing LacG071 line, and Saha063
and Saha100 are the animals that belonged to Rosa26 antisense lines.
Figures 4.1 to 4.5 showed how well the neural markers could detect the actual cell type in
the presence of Res-gal and DAPI. Figure 4.6 shows the detection of microglial marker
(IBA-1) with the help of immunostaining. This case is, however, free from Res-gal.
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Next, we wanted to detect these three signals with the help of QuPath. And we could
successfully code a script which perfectly detected different signals, belonged to different
channels (RGB) (Fig. 4.7a). Figure 4.7b shows the concept for the quantification of colocalizing signals. Here only those cells colocalizing three colors are expressed in
percentage value.
Figure 4.8 shows all types of colocalizing detections detection was necessarily containing
DAPI signals in it. Here, different color codes are used to mark different types of
detections.
Figure 4.9 (a) and figure 1.9 (b) shows the total percentage of cells showing colocalization
of three signals at once for NeuN and Sox-2 markers, respectively.
A sample contrast between two thalamic regions of two different lines (Fig. 4.10), Rosa26
antisense line and LacG071 line. It represented almost a similar number of cells stained
with Res-gal. It also indicated that all the Res-gal signals were nuclear-localized.
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GFAP
a. N804 (hippocampus)

20X
b. Saha100 (hypothalamus)

40X
Color codes: Green = GFAP cells ; Blue = Dapi; Red= Resgal
Figure 4.1. Detection of the GFAP expressing astrocytes (green) in the hippocampus (a)
and hypothalamus (b) of the brain of animals belonging to LacG071 line and the Rosa 26
antisense lines, respectively. In these confocal images, Res-gal fluorescence (red) was
found to be co-localized in the DAPI stained nuclei (blue) cells.
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Olig-2
A. N804 (Thalamus)

20X
b. Saha100 (Brain stem)

20X
Color codes: Green = Olig-2 cells ; Blue = Dapi; Red= Resgal
Figure 4.2: Detection of the Olig-2 expressing oligodendrocytes (green) in the thalamus
(a) and brain stem (b) of the brain of animals belonging to LacG071 line and the Rosa 26
antisense lines, respectively. In these confocal images, Res-gal fluorescence (red) was
found to be co-localized in the DAPI stained nuclei (blue) cells.
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NeuN
a. N804 (Thalamus)

20X
b. Saha063 (Cortex)

20X
Color codes: Green = NeuN cells ; Blue = Dapi; Red= Resgal
Figure 4.3. Detection of the NeuN expressing neurons (green) in the thalamus (a) and
brain cortex (b) of the brain of animals belonging to LacG071 line and the Rosa 26
antisense lines, respectively. In these confocal images, Res-gal fluorescence (red) was
found to be co-localized in the DAPI stained nuclei (blue) cells.
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Sox2
a. N804 (Subventricular zone)

20X
b. Saha100 (Subgranular zone)

20X
Color codes: Green = Sox-2 cells; Blue = Dapi; Red= Resgal
Figure 4.4. Detection of the Sox-2 expressing stem cells (green) in the subventricular
zone (a) and subgranular zone (b) of the brain of animals belonging to LacG071 line and
the Rosa 26 antisense lines, respectively. In these confocal images, Res-gal fluorescence
(red) was found to be co-localized in the DAPI stained nuclei (blue) cells.
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NG2
a. N804 (hypothalamus)

20X
b. Saha100 (Subgranular zone)

20X
Color codes:

Green = NG2 cells; Blue = Dapi; Red= Resgal

Figure 4.5. Detection of the NG2 expressing oligodendrocyte progenitor cells (green) in
the hypothalamus (a) and subgranular zone (b) of the brain of animals belonging to
LacG071 line and the Rosa 26 antisense lines, respectively. In these confocal images,
Res-gal fluorescence (red) was found to be co-localized in the DAPI stained nuclei (blue)
cells.
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Anti IBA-1 detection

Primary antibody: Rabbit Anti-IBA-1
Secondary antibody: Donkey anti-rabbit Alexa F594
Blue = Dapi; Red= IBA-1
Figure 4.6. Detection of the IBA-1 expressing microglial cells (red) in the hypothalamus
of the brain of the animal, Saha100, belonging to the Rosa 26 antisense lines. DAPI
stained nuclei (blue) cells.

QuPath detection
a. Detection of immunofluorescence signals
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b. Venn diagram conceptualizing the calculation

Figure 4.7. QuPath detection. (a) A real-time detection of immunofluorescence signals
& (b) Venn diagram conceptualizing the calculation of the percentage of transgene
expressing brain cell markers. The calculation was made using a mathematical formula
mentioned in the inset (where, F= number of cells expressing cell markers, D = DAPI
stained nuclei, & R= Res-gal stained cells).

a. All channels

b. Only DAPI detection

c. Only red detection

d. Only cell marker
(green) detection

e. Detection of the elements co-localizing all three
colors
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Figure 4.8. Effectiveness of QuPath enforced detection. Here, different detections
denoted with multiple colors (a) have been segregated into specific condition combining
individual colors (b-e).

a. Brain maker (NeuN)

b. Sox 2 marker

Figure 4.9. Percentage of Res-gal positive cells in different parts of mouse brains
expressing markers, (a) NeuN & (b) Sox2.

160

a. Thalamus of N804

Resgal signals alone

Resgal colocalized with DAPI

b. Thalamus of Saha100

Resgal signals alone
Resgal colocalized with DAPI
Figure 4.10. The difference in Res-gal signals between two thalamic regions of two
different lines, (a) LacG071 & (b) Rosa26 antisense line.
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4.5 Discussion
The primary idea of this chapter was to detect the transgene positive brain markers. Due to
the presence of the LacG reporter cassette in our transgene, our transgene, if translated will
translate into the beta-galactosidase enzyme, which can enzymatically break down many
chromogenic and fluorogenic substrate. Resorufin β-D-galactopyranoside (or, Res-gal) is
a fluorogenic substrate, which when breaks down form a fluorescence emitting substance.
Here, we wanted to replace X-gal with this compound since both of them share the same
mechanism for detection. Moreover, when we use it in conjunction with DAPI and a
secondary antibody with a fluorophore attached to it. In a successful detection of primary
antibody, we shall get the overall result in a fluorescent form, again provided that transgene
is expressed and the product degrades the Res-gal.
For the in situ detection of the cells, samples from two different mouse line were chosen,
especially those which shows promoter activity in terms of X-gal signals. Such mouse lines
are Rosa26 line and mot expressing LacG071 subline. We optimized an immunostaining
protocol to use the Res-gal, which we had to incorporate in the final step of incubation with
a secondary antibody.
We chose five different common brain markers for detection with the primary antibody.
They include the neuronal marker (NeuN), glial markers (NG2, Olig2, and GFAP), and
stem cell marker (Sox-2). All could be detected successfully, and their phenotypes were
verified with the help of experts. With a similar protocol, we could also successfully detect
IBA-1, a microglia marker. However, it had never been used in the presence of Res-gal
(Fig. 4.6).
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As expected, we obtained the Res-gal signals colocalizing in the nuclear mostly. Therefore,
we wanted to detect the percentage of cells that are at the same time detected by cell
markers and express Res-gal. These classes of cells are, in other words, transgene
expressing specific brain cells.
And we took the help of a pathological quantifying software, QuPath to detect the
fluorescence signals separately and effectively. We made generated the script in such a
way that DAPI signal as essential criteria to be present for each of the co-localization and
ruled out any combination not having DAPI signal excluded.
The images were taken in confocal microscopy from different brain regions. After image
processing, we quantified the percentage of cells in each of the brain regions. The results
of the analyses (Fig. 4.9 a & b) indicated a background problem for the Res-gal. It meant
although the Res-gal signals were nuclear-bound, yet we observed the same abundance of
signals in both of these mouse lines (Fig. 4.10). However, the X-gal data did not turn in
with such a result. Therefore, it was concluded that though X-gal and Res-gal share similar
degradation pathways by beta-galactosidase, there is a major difference in their sensitivity.
It was possible that these substrates got broke down within a short period and had enough
time to diffuse some other parts of the same section while being incubated.
Therefore, this technique can be optimized further with different duration of incubation or
by finding an alternative substrate with lesser sensitivity.
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Chapter 5
General discussion and future directions

In this project, we successfully characterized a few critical aspects of the LINE-1 promoter
activity in our transgenic mouse model. We attempted to take a deep insight into the
determinant factors, which would alter promoter activity in the various situation with
regards to transgenic expression.
First, we were able to show that each integration site for the transgene brought about a
distinct change of promoter activity either as stable or silencing. This position effect
confirms the critical importance of the site of integration on the level of LINE-1 promoter
activity. Surprisingly enough, this position effect, again, in turn, can be governed by
changing the orientation of the cassette. This phenomenon could let us understand why
some individuals are more susceptible to LINE-1 mediated disorder, while some are
unaffected. In other words, this locus and orientation-dependent expression pattern also let
us agree that permissiveness of loci and their transcriptional influence on the LINE-1
promoter can possess a risk for some LINE-1 medicated diseases. Therefore, evaluating
locus-specific permissiveness can be a better biomarker than carrying out the same to
assess global LINE-1 expression or methylation status.
Second, through our endeavor, it was possible to understand that some organs have no, low
or high LINE-1 promoter activity – of course depending on the age of the host. To our best
knowledge, this was the first approach of this kind to understand the in vivo organ-specific
regulation with considering development-time a factor. The same technique can be
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diversified to more number of organs of this mouse model; thus, we could get better organspecific information. In addition, RNA and protein detection approaches can be included
to validate our staining data. Studying the promoter activity in cancer/other disease model
would be helpful to broaden our perspectives on the regulation of the LINE-1 activities in
respective conditions.
Third, our current knowledge regarding the cell-types holding the retrotransposition events
is limited. Still, it is also unknown when cells lose control to repress these “molecular
parasites” in them and when they cannot. The attempt of understanding cell-specific
regulation to the LINE-1 promoter activity can be continued. It might give us an insight
into how the diverse population of different cell types, not only in the brain but elsewhere
in the organ system can promote or repress LINE-1 activity.
The technique relies on a very simple staining technique. It is very handy and costeffective, and also can be adopted by any laboratory in a short period. The effect of various
physiological, pathological, chemical, or environmental factors on LINE-1 mobilization
can be assayed. For example, the effect of different carcinogens or potential drug
candidates can be screened for their roles in triggering or barring retrotransposition. It is
strongly believed that with the help of our technique and mouse model in combination, a
wide range of chemicals can be assessed within a short time.
Overall remark regarding this study is, this study may carry consistency with the previous
ground-breaking works by Brouha et al., 2003, Pizarro and Cristofari, 2016 and finally,
Philippe et al., 2016 (Brouha et al., 2003; Pizarro and Cristofari, 2016; Philippe et al.,
2016). Although these works are strong in their context; however, they all commonly crosstalked about the locus-dependency with retrotransposition-competency. Here, we showed
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in situ that indeed there is a locus-dependency - complicated by age, organ and orientation
factors - for LINE-1 to be expressed in mammals.
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